var title_f10_4_10304="Porphyria cutanea tarda 3";
var content_f10_4_10304=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F56810&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F56810&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Porphyria cutanea tarda: bullous skin lesion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 250px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bullous lesion on the hand of a patient with porphyria cutanea tarda. Erythema, erosions, and crusting are also seen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Karl E Anderson, MD, FACP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_4_10304=[""].join("\n");
var outline_f10_4_10304=null;
var title_f10_4_10305="Dibekacin: International drug information";
var content_f10_4_10305=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Dibekacin: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F1978491\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Debekacyl (JP, LU);",
"     </li>",
"     <li>",
"      Decabicin (ES);",
"     </li>",
"     <li>",
"      Dikacine (BE, LU);",
"     </li>",
"     <li>",
"      DKB-GT (JP);",
"     </li>",
"     <li>",
"      Ibekacin (AR);",
"     </li>",
"     <li>",
"      Icacine (FR);",
"     </li>",
"     <li>",
"      Klobamicina (ES);",
"     </li>",
"     <li>",
"      Nipocin (HR);",
"     </li>",
"     <li>",
"      Panimycin (JP)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list synlist drugH1Div drugBrandNames\" id=\"F1978481\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Index Terms",
"    </span>",
"    <ul>",
"     <li>",
"      Dibekacine Sulfate",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1978485\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic, Aminoglycoside",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1978488\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of septicemia, plurifocal infections, urinary tract infections, gyno-obstetrical infections, and bronchopulmonary infections caused by susceptible",
"     <i>",
"      Staphylococcus",
"     </i>",
"     and gram-negative organisms",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1978484\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: I.V.: 1-3 mg/kg daily in divided doses",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821235\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1978487\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection, solution: 75 mg/1.5 mL",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10365 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-178.219.2.221-4EAA1F1B94-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_4_10305=[""].join("\n");
var outline_f10_4_10305=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978491\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978481\">",
"      Index Terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978485\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978488\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978484\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821235\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978487\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10365\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10365|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_4_10306="CT gastric outlet obstruct";
var content_f10_4_10306=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F58277&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F58277&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    CT of the abdomen in a patient with gastric outlet obstruction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 328px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Abdominal CT in a patient with gastric outlet obstruction due to peptic ulcer disease showing a distended and fluid filled stomach.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ashley Davidoff, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_4_10306=[""].join("\n");
var outline_f10_4_10306=null;
var title_f10_4_10307="McRoberts position";
var content_f10_4_10307=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F58081&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F58081&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Effect of McRoberts positioning relative to lithotomy position",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 232px; height: 451px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A: The patient's legs have been hyperflexed by assistants. The 16 degree rotation for a 10.5-cm obstetric conjugate (ideally) moves the symphisis pubis 9 mm anteriorly and 28 mm in a cephalad direction. B: Lithotomy position.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Poggi, SH, Spong, CY, Allen, AH. Prioritizing posterior arm delivery during severe shoulder dystocia. Obstet Gynecol 2003; 101:1068. Copyright &copy; 2003 American College of Obstetricians and Gynecologists.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_4_10307=[""].join("\n");
var outline_f10_4_10307=null;
var title_f10_4_10308="Middle phalanx fracture displacement";
var content_f10_4_10308=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F80728&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F80728&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 474px\">",
"   <div class=\"ttl\">",
"    Middle phalanx fracture displacement",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 454px; height: 391px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) A lateral view, showing the prolonged insertion of the flexor superficialis tendon into the middle phalanx. B) A fracture through the neck of the middle phalanx is likely to have a volar angulation because the proximal fragment is flexed by the strong pull of the superficialis. C) A fracture through the base of the middle phalanx is more likely to have a dorsal angulation because of the extension force of the central slip on the proximal fragment and a flexion force on the distal fragment by the superficialis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Rockwood CA Jr, Green DP, Bucholz RW, Heckman JD, eds. Rockwood and Green's Fractures in Adults, 4th ed. Philadelphia: Lippincott-Raven, 1996: Copyright &copy; 1996 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_4_10308=[""].join("\n");
var outline_f10_4_10308=null;
var title_f10_4_10309="Psoralens";
var content_f10_4_10309=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83609&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83609&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 501px\">",
"   <div class=\"ttl\">",
"    Psoralens",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 481px; height: 669px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     <p>",
"      &nbsp;",
"     </p>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_4_10309=[""].join("\n");
var outline_f10_4_10309=null;
var title_f10_4_10310="Demeclocycline: Drug information";
var content_f10_4_10310=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Demeclocycline: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?37/49/38676?source=see_link\">",
"    see \"Demeclocycline: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/5/6229?source=see_link\">",
"    see \"Demeclocycline: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F157470\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antibiotic, Tetracycline Derivative",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F157442\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Susceptible infections:",
"     </b>",
"     Manufacturer&rsquo;s labeling: Oral: 150 mg 4 times/day or 300 mg twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      SIADH (unlabeled use):",
"     </b>",
"     Oral: 600-1200 mg/day (Goh, 2004; Gross, 2008)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F157459\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/5/6229?source=see_link\">",
"      see \"Demeclocycline: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Susceptible infections:",
"     </b>",
"     Manufacturer&rsquo;s labeling: Oral: Children &gt;8 years: 7-13 mg/kg/day (maximum: 600 mg/day) divided every 6-12 hours",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F157443\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F157444\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution; dosage adjustment and/or increase in time interval between doses recommended in manufacturer&rsquo;s labeling; no specific adjustment recommendations provided.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F157445\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution; dosage adjustment and/or increase in time interval between doses recommended in manufacturer&rsquo;s labeling; no specific adjustment recommendations provided.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F157414\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as hydrochloride: 150 mg, 300 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F157398\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F157417\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer 1 hour before or 2 hours after food or milk. Administer with adequate amounts of fluid to decrease the risk of esophageal irritation and ulceration.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F157416\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of susceptible bacterial infections (eg, acne, urinary tract infections, respiratory infections) caused by both gram-negative and gram-positive organisms",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Use of demeclocycline as an antibacterial agent is uncommon; alternative tetracycline agents (eg, doxycycline, minocycline, tetracycline) are generally preferred.",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F157467\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone (SIADH)",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F157468\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Pericarditis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Bulging fontanels (infants), dizziness, headache, pseudotumor cerebri (adults)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Angioedema, anogenital inflammatory lesions (with monilial overgrowth), erythema multiforme, erythematous rash, exfoliative dermatitis (rare), maculopapular rash, photosensitivity, pigmentation of skin, Stevens-Johnson syndrome (rare), urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Microscopic discoloration of thyroid gland (brown/black), nephrogenic diabetes insipidus, thyroid dysfunction (rare)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Anorexia, diarrhea, dysphagia, enterocolitis, esophageal ulcerations, glossitis, nausea, pancreatitis, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Balanitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Eosinophilia, neutropenia, hemolytic anemia, thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Hepatitis (rare), hepatotoxicity (rare), liver enzymes increased, liver failure (rare)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Myasthenic syndrome, polyarthralgia, tooth discoloration (children &lt;8 years, rarely in adults)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Visual disturbances",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Tinnitus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Acute renal failure, BUN increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Pulmonary infiltrates",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Anaphylaxis, anaphylactoid purpura, fixed drug eruptions (rare), lupus-like syndrome, superinfection, systemic lupus erythematosus exacerbation",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F157420\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to demeclocycline, tetracyclines, or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F157402\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes insipidus syndrome: Dose-dependent nephrogenic diabetes insipidus is common with use; however, this adverse event of demeclocycline has been used as a therapeutic advantage in the off-label use of hyponatremia associated with SIADH.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Increased BUN: May be associated with increases in BUN secondary to antianabolic effects; use caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Photosensitivity: May cause photosensitivity; discontinue if skin erythema occurs. Use skin protection and avoid prolonged exposure to sunlight; do not use tanning equipment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pseudotumor cerebri: Has been (rarely) reported with tetracycline use; usually resolves with discontinuation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Superinfection: Prolonged use may result in fungal or bacterial superinfection, including",
"     <i>",
"      C. difficile",
"     </i>",
"     -associated diarrhea (CDAD) and pseudomembranous colitis; CDAD has been observed &gt;2 months postantibiotic treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment; dose adjustment and/or adjustment to interval frequency recommended. Hepatotoxicity and hepatic failure have been reported rarely with use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment; dosage adjustment recommended. Nephrotoxicity has also been reported with use, particularly in the setting of cirrhosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Methoxyflurane: Concurrent use of tetracyclines and methoxyflurane (not available in the U.S.) is not recommended; fatal renal toxicity has been reported with concurrent use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: May cause tissue hyperpigmentation, enamel hypoplasia, or permanent tooth discoloration; use of tetracyclines should be avoided during tooth development (children &lt;8 years of age) unless other drugs are not likely to be effective or are contraindicated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pregnancy: Do not use during pregnancy. In addition to affecting tooth development, tetracycline use has been associated with retardation of skeletal development and reduced bone growth.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299132\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F157407\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antacids: May decrease the absorption of Tetracycline Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Antibiotics may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bile Acid Sequestrants: May decrease the absorption of Tetracycline Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bismuth: May decrease the serum concentration of Tetracycline Derivatives. Management: Consider dosing tetracyclines 2 hours before, or 6 hours after, bismuth. The need to separate doses during Helicobacter pylori eradication regimens is questionable.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bismuth Subsalicylate: May decrease the serum concentration of Tetracycline Derivatives. Management: Consider dosing tetracyclines 2 hours before, or 6 hours after, bismuth subsalicylate. The need to separate doses during Helicobacter pylori eradication regimens is questionable.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Salts: May decrease the serum concentration of Tetracycline Derivatives. Management: If coadministration of oral calcium with oral tetracyclines can not be avoided, consider separating administration of each agent by several hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Desmopressin: Demeclocycline may diminish the therapeutic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iron Salts: May decrease the absorption of Tetracycline Derivatives. Only a concern with orally administered products.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Ferric Gluconate; Ferumoxytol; Iron Dextran Complex; Iron Sucrose.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lanthanum: May decrease the serum concentration of Tetracycline Derivatives. Management: Administer oral tetracycline antibiotics at least two hours before or after lanthanum.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Salts: May decrease the absorption of Tetracycline Derivatives. Only applicable to oral preparations of each agent.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mipomersen: Tetracycline Derivatives may enhance the hepatotoxic effect of Mipomersen.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May decrease the serum concentration of Tetracycline Derivatives. Management: If coadministration of a polyvalent cation-containing multivitamin with oral tetracyclines can not be avoided, separate administration of each agent by several hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular-Blocking Agents: Tetracycline Derivatives may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Penicillins: Tetracycline Derivatives may diminish the therapeutic effect of Penicillins.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Porfimer: Photosensitizing Agents may enhance the photosensitizing effect of Porfimer.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinapril: May decrease the serum concentration of Tetracycline Derivatives. Management: Separate doses of quinapril and oral tetracycline derivatives by at least 2 hours in order to reduce the risk of interaction. Monitor for reduced efficacy of the tetracycline if these products are used concomitantly.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Retinoic Acid Derivatives: Tetracycline Derivatives may enhance the adverse/toxic effect of Retinoic Acid Derivatives. The development of pseudotumor cerebri is of particular concern.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Adapalene; Alitretinoin; Tretinoin (Topical).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Strontium Ranelate: May decrease the serum concentration of Tetracycline Derivatives. Management: In order to minimize any potential impact of strontium ranelate on tetracycline antibiotic concentrations, it is recommended that strontium ranelate treatment be interrupted during tetracycline therapy.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sucralfate: May decrease the absorption of Tetracycline Derivatives. Management: Administer the tetracycline derivative at least 2 hours prior to sucralfate in order to minimize the impact of this interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Typhoid Vaccine: Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected.  Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents.  Use of this vaccine should be postponed until at least 24 hours after cessation of antibacterial agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Tetracycline Derivatives may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zinc Salts: May decrease the absorption of Tetracycline Derivatives. Only a concern when both products are administered orally.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Zinc Chloride.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F157433\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Food: Demeclocycline serum levels may be decreased if taken with food, milk, or dairy products. Management: Administer 1 hour before or 2 hours after food, milk, or dairy products.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: Some herbal medications may cause photosensitization. Management: Avoid dong quai and St John's wort.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F157410\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     D (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F157423\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Tetracyclines, including demeclocycline, cross the placenta and accumulate in developing teeth and long tubular bones. Tetracyclines may discolor fetal teeth following maternal use during pregnancy; the specific teeth involved and the portion of the tooth affected depends on the timing and duration of exposure relative to tooth calcification. As a class, tetracyclines are generally considered second-line antibiotics in pregnant women and their use should be avoided (Gibbons, 1960; Mylonas, 2011).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F157449\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F3414834\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Tetracyclines are excreted into breast milk. According to the manufacturer, the decision to continue or discontinue breast-feeding during therapy should take into account the risk of exposure to the infant and the benefits of treatment to the mother.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Tetracyclines, including demeclocycline, bind to calcium (Mitrano, 2009). The calcium in maternal milk will significantly decrease the amount of demeclocycline absorbed by the breast-feeding infant. Nondose-related effects could include modification of bowel flora.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F157424\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Due to potential for decreased absorption, administer 1 hour before or 2 hours after food or milk.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323096\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Demeclocycline HCl Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     150 mg (100): $942.34",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     300 mg (48): $819.24",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F157412\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     CBC, renal and hepatic function",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038596\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Alkonatrem Gel (FR);",
"     </li>",
"     <li>",
"      Compleciclin (ES);",
"     </li>",
"     <li>",
"      Demecline (TW);",
"     </li>",
"     <li>",
"      Ledermicina (IT);",
"     </li>",
"     <li>",
"      Ledermycin (AT, AU, BE, GB, GR, IE, IN, LU, NL, NZ, PK);",
"     </li>",
"     <li>",
"      Perciclina (PT);",
"     </li>",
"     <li>",
"      Provimicina (ES)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F157401\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits protein synthesis by binding with the 30S and possibly the 50S ribosomal subunit(s) of susceptible bacteria; may also cause alterations in the cytoplasmic membrane; inhibits the action of ADH in patients with chronic SIADH",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F157419\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: SIADH: 2-5 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: 66%; extent of absorption is reduced by food and by certain antacids and dairy products containing aluminum, calcium, magnesium, or iron",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: 1.7 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 40% to 90%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: None",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 10-16 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: ~4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (44% as unchanged drug); feces (13% to 46% as unchanged drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Agwuh KN and MacGowan A, \"Pharmacokinetics and Pharmacodynamics of the Tetracyclines Including Glycylcyclines,\"",
"      <i>",
"       J of Antimicrob Chemother",
"      </i>",
"      , 2006, 58(2):256-65.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/4/10310/abstract-text/16816396/pubmed\" id=\"16816396\" target=\"_blank\">",
"        16816396",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;American Academy of Pediatrics Committee on Drugs. The Transfer of Drugs and Other Chemicals Into Human Milk,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(3):776-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/4/10310/abstract-text/11533352/pubmed\" id=\"11533352\" target=\"_blank\">",
"        11533352",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gibbons RJ and Reichelderfer TE, \"Transplacental Transmission of Demethylchlortetracycline and Toxicity Studies in Premature and Full Term, Newly Born Infants,\"",
"      <i>",
"       Antibiotic Med Clin Ther",
"      </i>",
"      , 1960, 7:618-22.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/4/10310/abstract-text/13705067/pubmed\" id=\"13705067\" target=\"_blank\">",
"        13705067",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Goh KP, \"Management of Hyponatremia,\"",
"      <i>",
"       Am Fam Physician",
"      </i>",
"      , 2004, 69(10):2387-94.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/4/10310/abstract-text/15168958/pubmed\" id=\"15168958\" target=\"_blank\">",
"        15168958",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gross P, \"Treatment of Hyponatremia,\"",
"      <i>",
"       Intern Med",
"      </i>",
"      , 2008, 47(10):885-91.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/4/10310/abstract-text/18480571/pubmed\" id=\"18480571\" target=\"_blank\">",
"        18480571",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mitrano JA, Spooner LM, and Belliveau P, \"Excretion of Antimicrobials Used to Treat Methicillin-Resistant",
"      <i>",
"       Staphylococcus aureus",
"      </i>",
"      Infections During Lactation: Safety in Breastfeeding Infants,\"",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2009, 29(9):1103-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/4/10310/abstract-text/19698015/pubmed\" id=\"19698015\" target=\"_blank\">",
"        19698015",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mylonas I, \"Antibiotic Chemotherapy During Pregnancy and Lactation Period: Aspects for Consideration,\"",
"      <i>",
"       Arch Gynecol Obstet",
"      </i>",
"      , 2011, 283(1):7-18.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/4/10310/abstract-text/20814687/pubmed\" id=\"20814687\" target=\"_blank\">",
"        20814687",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pasquale TR and Tan JS, \"Nonantimicrobial Effects of Antibacterial Agents,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2005, 40(1):127-35.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/4/10310/abstract-text/15614702/pubmed\" id=\"15614702\" target=\"_blank\">",
"        15614702",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sherlock M and Thompson CJ, \"The Syndrome of Inappropriate Antidiuretic Hormone: Current and Future Management Options,\"",
"      <i>",
"       Eur J Endocrinol",
"      </i>",
"      , 2010, 162(Suppl 1):13-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/4/10310/abstract-text/20164215/pubmed\" id=\"20164215\" target=\"_blank\">",
"        20164215",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9328 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-83.177.194.223-2AD339225F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_4_10310=[""].join("\n");
var outline_f10_4_10310=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157470\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157442\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157459\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157443\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157444\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157445\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157414\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157398\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157417\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157416\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157467\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157468\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157420\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157402\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299132\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157407\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157433\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157410\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157423\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157449\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3414834\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157424\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323096\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157412\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038596\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157401\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157419\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9328\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9328|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?37/49/38676?source=related_link\">",
"      Demeclocycline: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/5/6229?source=related_link\">",
"      Demeclocycline: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_4_10311="Preparation for labor and childbirth";
var content_f10_4_10311=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Preparation for labor and childbirth",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/4/10311/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/4/10311/contributors\">",
"     Judith A Lothian, RN, PhD, LCCE",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/4/10311/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/4/10311/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/4/10311/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/4/10311/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/4/10311/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 23, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A woman's experience of birth is vitally important, and her birth memories endure [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Four factors are particularly important in determining a woman's childbirth experience: personal expectations, the amount of support she receives, the quality of the caregiver-patient relationship, and her involvement in decision making [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Women have always prepared for the birth of their babies. Mothers from all cultures traditionally passed their knowledge about labor and birth to their daughters. These cultural and family rituals guided women through pregnancy, labor, birth, and the early days of mothering. Much of women's wisdom about birth was lost when birth moved from home to hospital. Mothers, sisters, and other women knowledgeable about birth no longer attended the woman. Birth became a medical event and cultural and family rituals took a back seat, eventually all but disappearing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/4\">",
"     4",
"    </a>",
"    ]. The development of structured educational programs in preparation for childbirth came about as the traditional methods of information sharing declined [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Nurses and physical therapists who knew a great deal about the mechanics and medical management of pregnancy, labor, and birth, began to educate women about childbirth, largely outside of the health care system. Eventually these professionals became formally trained as childbirth educators [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/5\">",
"     5",
"    </a>",
"    ]. Childbirth education focused on two things in those early years: the basic anatomy and physiology of labor and birth and simple strategies (typically relaxation and breathing) to cope with the pain of contractions.",
"   </p>",
"   <p>",
"    We now know a great deal now about the role of pain in labor [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/6\">",
"     6",
"    </a>",
"    ], the wide and ever increasing number of ways that women find comfort during labor and birth [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/7\">",
"     7",
"    </a>",
"    ], and the importance of continuous emotional and physical support during parturition [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. In addition, some traditional birth practices, such as movement during labor, physiologic pushing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/11\">",
"     11",
"    </a>",
"    ], and the upright position for second stage have been shown to be effective practices in controlled studies [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Women now prepare for labor and birth with much more knowledge than women did forty years ago.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GOALS OF PREPARATION FOR LABOR AND BIRTH",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major goals of childbirth education are that women labor and give birth [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Confident in their own ability to give birth",
"     </li>",
"     <li>",
"      Able to find comfort as labor progresses",
"     </li>",
"     <li>",
"      Supported by family, friends, and professionals",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Birth preparation should provide women with the knowledge and support they need to make informed decisions that are right for them. Ultimately, preparing for birth can help set the stage for women remembering their births with the best possible memories, even if complications develop and medical interventions are needed [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Coping with pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pain associated with childbirth is a concern of most pregnant women; although interestingly, pain and pain relief do not play a major role in a woman's satisfaction with her childbirth experience [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/3,16\">",
"     3,16",
"    </a>",
"    ]. Childbirth education helps women understand the role pain plays in normal labor and birth: bringing support, protecting the birth canal, ensuring high levels of endorphins and oxytocin. Women learn that actively working with pain, rather than eliminating it entirely, can facilitate the progress of labor. Women are encouraged to actively respond to their contractions during the first stage of labor, and to push when they feel the urge during second stage (physiologic pushing). Childbirth education addresses modifiable factors that help alleviate labor pain and enhance women's self-confidence. Such factors include controlling the labor and birth environment so that women feel safe and able to find comfort in a variety of ways, coping strategies, and addressing expectations and anxiety about the birth experience [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/15\">",
"     15",
"    </a>",
"    ]. If women are actively able to work with their contractions in labor they experience a sense of accomplishment, feel less pain, and do not suffer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     WHAT WOMEN NEED TO KNOW",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evidence-based care practices that promote, protect and support normal birth provide the foundation for essential content in a childbirth preparation course [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. The components of childbirth preparation include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The normal, natural physiologic process of labor and birth",
"     </li>",
"     <li>",
"      What facilitates normal physiologic labor, and what makes giving birth normally more difficult",
"     </li>",
"     <li>",
"      Signs of labor; distinguishing prodromal from active labor",
"     </li>",
"     <li>",
"      When and how to call the health care provider",
"     </li>",
"     <li>",
"      What to expect in the hospital, policies, and resources",
"     </li>",
"     <li>",
"      Ways that laboring women find comfort; the importance of labor support",
"     </li>",
"     <li>",
"      The role of pain in labor: the physiology of endogenous and exogenous oxytocin",
"     </li>",
"     <li>",
"      Possible complications of labor (eg, prolonged labor, nonreassuring fetal heart rate): both prevention and management",
"     </li>",
"     <li>",
"      How routine interventions and complications influence the normal course of labor",
"     </li>",
"     <li>",
"      Newborn issues (eg, circumcision, choosing a pediatrician, infant needs and capabilities, rooming-in)",
"     </li>",
"     <li>",
"      The importance of breastfeeding, how to prepare and get started breastfeeding",
"     </li>",
"     <li>",
"      What to expect when the baby goes home, including planning for support",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following examples illustrate some of the benefits of childbirth education:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study, nulliparous women were randomized to routine care or specific teaching about palpation of the uterine fundus, differentiation between Braxton-Hicks and active labor contractions, timing of contractions, recognition of amniotic fluid leak, and pain perception, with reinforcement of these concepts at antenatal visits [",
"      <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/19\">",
"       19",
"      </a>",
"      ]. The number of visits to the labor suite that resulted in the patient being discharged undelivered was lower in women who received the educational intervention.",
"     </li>",
"     <li>",
"      Another randomized trial showed that low income black women who received information on the myths, problems, and benefits of breastfeeding were more likely to breast feed their infants [",
"      <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A program that randomly assigned 1193 nulliparous women to receive nine hours of formal childbirth education or usual care found that the women who received comprehensive childbirth education were more likely to be admitted in active labor and less likely to use epidural anesthesia than the usual care group, but medical interventions and patient satisfaction with the childbirth experience were similar in both groups [",
"      <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/21\">",
"       21",
"      </a>",
"      ]. Almost 50 percent of the usual care group also received some type of childbirth education.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The purpose of antenatal education is to help prospective parents prepare for childbirth and parenthood by providing information on issues such as evidence-based maternity care practices, pain relief, decision making during labor, infant and postnatal care, and breastfeeding, as well as increasing maternal confidence. However, there is a lack of high-quality evidence from controlled trials to assess the results of antenatal education or determine the best approach, especially since few women are willing to be randomized to no formal antenatal preparation [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. Further research is required to ensure that these classes best meet the needs of parents and their newborn infants.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Support during labor and delivery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of an individual supporting the laboring woman appears to have both psychological and medical benefits. A Cochrane systematic review involving almost 13,000 women found the continuous presence of a support person reduced the likelihood of medication for pain relief, operative vaginal delivery, cesarean delivery, and the reporting of dissatisfaction with the birth experience [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/10\">",
"     10",
"    </a>",
"    ]. Continuous support is also associated with a slight reduction in the length of labor and improvement in maternal satisfaction (eg, coping during labor, level of personal control during childbirth) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/20/22855?source=see_link\">",
"     \"Continuous intrapartum support\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A home-like birth environment also has beneficial effects. Another Cochrane review found that low risk women giving birth in this setting used less analgesia, had fewer operative deliveries, and were more satisfied with their birth experience and more likely to be breastfeeding two months postpartum [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/24\">",
"     24",
"    </a>",
"    ]. They also used less epidural analgesia and had less oxytocin augmentation and fewer episiotomies. However, increased support from caregivers typical of this setting may be an important factor affecting outcome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     WHAT TO DO TO PREPARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Much of the preparation for labor and birth happens quite naturally as pregnancy progresses. Mother becomes attached to her baby as he makes his presence known with kicks and movement. Physical changes occur: the cervix softens, contractions become noticeable. She begins to tire of being pregnant and often gets a burst of energy right before going into labor (\"nesting\"). Knowledge of the physiologic changes that indicate her body is preparing for labor and birth helps women develop confidence.",
"   </p>",
"   <p>",
"    Another way that prospective mothers prepare for labor and birth is by talking with other women, sharing stories, and getting guidance [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/25\">",
"     25",
"    </a>",
"    ]. This helps to foster feelings of connection with other women who have experienced labor and birth, and provides valuable information about ways that women manage the challenges of labor, birth, and early parenting.",
"   </p>",
"   <p>",
"    Being present at births or viewing birth on video also help prepare women for their own births. There are a number of excellent videos (many in DVD format) available in which women give birth confidently in a variety of settings. Two that the author highly recommends are Celebrate Birth [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/26\">",
"     26",
"    </a>",
"    ] and Open Minds To Birth [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are literally hundreds of books about pregnancy and birth, and an ever increasing number of web sites which contain information about pregnancy, labor, birth, and early parenting. However, in spite of the wealth of information that is available, many resources contain inaccuracies and increase women's fears about labor and birth. The author recommends The Official Lamaze Guide: Giving Birth with Confidence [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/15\">",
"     15",
"    </a>",
"    ], Birthing from Within [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/28\">",
"     28",
"    </a>",
"    ], Ina May's Guide to Childbirth [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/29\">",
"     29",
"    </a>",
"    ], and Our Bodies, Ourselves Pregnancy and Birth Book [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/30\">",
"     30",
"    </a>",
"    ]. Lamaze International (",
"    <a class=\"external\" href=\"file://www.lamaze.org/\">",
"     www.lamaze.org",
"    </a>",
"    ), Childbirth Connection (",
"    <a class=\"external\" href=\"file://www.childbirthconnection.org/\">",
"     www.childbirthconnection.org",
"    </a>",
"    ) and the Coalition for Improving Maternity Services (",
"    <a class=\"external\" href=\"file://www.motherfriendly.org/\">",
"     www.motherfriendly.org",
"    </a>",
"    ) websites are excellent resources for women and professionals.",
"   </p>",
"   <p>",
"    All women come to labor and birth with some ability to deal with discomfort, reduce stress, and cope based upon their life experiences. Dealing with discomforts of pregnancy, including nausea, leg cramps, heartburn, and weight changes are very good practice for labor. The Birth Partner: A Complete Guide to Childbirth for Dads, Doulas, and All Labor Companions [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/31\">",
"     31",
"    </a>",
"    ] and the Labor Progress Handbook [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/32\">",
"     32",
"    </a>",
"    ] are excellent resources that walk the reader through specific comfort measures that laboring women find useful and practical during labor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Childbirth education",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prepregnancy or early pregnancy classes can provide information and discussion that help women make the initial decisions of choosing a health care provider and place of birth and learning about common issues of the first and second trimesters. In the last trimester, most women find formal childbirth education classes a good way to prepare for birth. It is an opportunity to meet with other pregnant women; share stories; obtain knowledge about pregnancy, labor, birth and postpartum issues; devote time to focusing on preparing for birth; and address fears and concerns. Fear of childbirth has been associated with longer labor duration [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/33\">",
"     33",
"    </a>",
"    ]. Formal childbirth education not only helps women know what to expect during labor and birth, but provides a forum for ultimately making choices within the context of modern maternity care and developing a personal plan for birth (see",
"    <a class=\"local\" href=\"#H8\">",
"     'Birth plans'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    The term &lsquo;natural childbirth&rsquo; is sometimes used to describe a method of childbirth where medical intervention for management of pain or labor is minimized. There are various methods of natural childbirth, which can be confusing. Some of the more common approaches are summarized below. It is important to know that over time the distinctions between \"methods\" have blurred.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Grantly Dick-Read told women that childbirth is not an inherently painful event. He described a \"fear-tension-pain\" syndrome in which fear produced tension in the myometrium leading to pain [",
"      <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/34\">",
"       34",
"      </a>",
"      ]. He designed an educational program to minimize fear and thus diminish the fear-tension-pain cycle and also an exercise regimen to prepare women for the exertion of labor.",
"     </li>",
"     <li>",
"      Fernand Lamaze combined the concepts of (1)",
"      <span class=\"nowrap\">",
"       preparation/education",
"      </span>",
"      to reduce fear and (2) conditioning to diminish the pain reflex (psychoprophylaxis) [",
"      <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/35\">",
"       35",
"      </a>",
"      ]. The key features of the Lamaze method were controlled deep breathing, light massage, concentrating on a focal point, active support by a labor coach, and the woman's control over her body and labor management.",
"      <br/>",
"      <br/>",
"      Contemporary Lamaze is quite different. The cornerstone of Lamaze preparation is a philosophy that affirms: birth as normal and natural, women's inherent ability to give birth, the importance of birth in women's lives, and the effect of the health care provider and place of birth on women's birth experiences [",
"      <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/15\">",
"       15",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Breathing is only one of many comfort strategies taught in Lamaze classes. Women in Lamaze classes are now encouraged to work with their labors, finding comfort in response to their contractions, and pushing in response to the urge to push, rather than controlling their bodies. The focus of classes is helping women have the safest, healthiest birth possible [",
"      <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Robert Bradley gave the woman's partner an active, major role (ie, husband-coached childbirth) and emphasized an extremely natural approach, with few or no drugs and little medical intervention during labor and delivery.",
"     </li>",
"     <li>",
"      Frederick LeBoyer proposed reducing stimuli that could affect the baby by turning down the lights, speaking quietly, giving a warm bath, and stressing gentleness. These actions are directed at the newborn, rather than support of the mother. The importance of keeping mother and baby together, addressed by LeBoyer, has been incorporated into all childbirth education approaches.",
"     </li>",
"     <li>",
"      Balaskas introduced the term \"active birth\" to describe an approach that helped mothers identify and develop their own bodily resources for birth and thus empower them through the birth experience [",
"      <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/37\">",
"       37",
"      </a>",
"      ]. Active birth reflects the growing knowledge we have of normal, natural birth and the ways in which it is facilitated. It is an important component of both Lamaze and Bradley.",
"     </li>",
"     <li>",
"      Hypnobirthing [",
"      <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/38\">",
"       38",
"      </a>",
"      ] is based on the belief that when a woman is prepared physically, mentally, and spiritually, she can experience the joy of birth in an easier, more relaxed, and potentially pain free manner. Self hypnosis and deep relaxation are important components of the method, but it, like other approaches, is eclectic and incorporates many other ways to find comfort and be confident in labor.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Birth plans",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preparing for labor and birth involves creating a plan for assuring that the three things that help women cope with labor and birth are in place: confidence in herself, freedom to reduce discomfort in a variety of ways, and support of family, friends and professionals [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. In the birth plan, the woman identifies what is important to her and what she needs to feel safe, supported and confident in labor. The birth plan is intended to be a living document that changes as circumstances change, acknowledging that medical interventions based on best evidence may be necessary if complications ensue. The strategies she develops to meet her goals will be different depending on her personal preferences, and where she will give birth (eg, hospital, birthing center, home). The birth plan should also include plans for early breastfeeding and the first minutes, days, and weeks of mothering.",
"   </p>",
"   <p>",
"    The written birth plan serves several purposes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It provides an opportunity for discussion between the woman and her partner or support team, as well as between the health care provider and the woman to ensure that all important issues are addressed. The provider and the support team learn what is personally important for the woman.",
"     </li>",
"     <li>",
"      It helps women become actively involved in making decisions, an important component of childbirth satisfaction.",
"     </li>",
"     <li>",
"      It provides a framework for developing a collaborative relationship between the health care provider and the woman. In some instances, it helps in resolving inconsistencies between the woman's expectations and what is considered best practice (for instance, if she has an epidural, she will need an intravenous line). It helps care providers (including nurses) to know the woman in a more personal way.",
"     </li>",
"     <li>",
"      It serves as documentation of the agreement between the provider and woman acknowledging that circumstances can change.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Ideally, written birth plans reduce conflicts and misunderstandings between women and their providers surrounding the birth by making agreements in advance about what will be done in a normal delivery and what will be necessary if an emergency arises. Typically, the written birth plan covers items listed in the table (",
"    <a class=\"graphic graphic_table graphicRef79039 \" href=\"UTD.htm?7/0/7180\">",
"     table 1",
"    </a>",
"    ). Unless there is a serious medical necessity, the birth plan and women's personal preferences should be honored.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     WHAT TO LOOK FOR IN A PREPARATION FOR CHILDBIRTH CLASS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Formal childbirth preparation classes should be taught by a certified childbirth educator [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/39\">",
"     39",
"    </a>",
"    ]. The knowledge and skills of the childbirth educator are different than the nurse's, the teacher's, and other health care professionals, although there is some overlap. The childbirth educator is knowledgeable about the normal, natural process of birth, including strategies to facilitate labor and birth. She is up to date with the most current research about birth and maternity care practices. In addition, she is a skilled teacher who does not just give the facts, but helps women make sense of what they are learning so they can ultimately make informed decisions about their labor and birth.",
"   </p>",
"   <p>",
"    There are a number of organizations that provide education",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    certification for childbirth education, although Lamaze is the only program accredited by NCCA, the national accreditation body for certifying agencies. The requirements of each program vary dramatically. No matter which group trains or certifies the childbirth educator, she should be knowledgeable about normal, natural birth, be familiar with the most current research about birth and maternity care practices, and be skilled at teaching groups.",
"   </p>",
"   <p>",
"    Childbirth classes should be small, with no more than eight to ten couples, to facilitate discussion and allow for individualized instruction [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/40\">",
"     40",
"    </a>",
"    ]. In general, classes should involve at least twelve hours of instruction. Traditionally, they are held over a period of weeks in the last trimester, although this model is being questioned [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. Helping women work through fears and develop confidence takes time, therefore, whether classes start early in pregnancy, are taught over a period of weeks or months, or during one long day, it is critical that there be adequate time for practice and discussion [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10311/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Class content at a very minimum should include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The normal, natural physiologic process of birth",
"     </li>",
"     <li>",
"      The care practices that promote, protect and support normal birth, including letting labor start on its own",
"     </li>",
"     <li>",
"      The history of birth",
"     </li>",
"     <li>",
"      The role of pain, including using pain as a guide to finding comfort in labor",
"     </li>",
"     <li>",
"      A wide variety of comfort measures, including not only simple relaxation and breathing techniques, but position changes such as walking and rocking, massage, hydrotherapy, aroma-therapy, music, use of hot and cold",
"     </li>",
"     <li>",
"      The importance of support, including a discussion of the value of professional labor support",
"     </li>",
"     <li>",
"      Ways to facilitate the progress of labor, such as ambulation",
"     </li>",
"     <li>",
"      Indications for medical interventions",
"     </li>",
"     <li>",
"      The effect of interventions, including the epidural, on the normal course of labor and birth",
"     </li>",
"     <li>",
"      Strategies to minimize the influence of interventions",
"     </li>",
"     <li>",
"      Complications of the normal, natural process of labor and birth",
"     </li>",
"     <li>",
"      How to keep labor as normal as possible if interventions are required",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Content should also include basic information about the importance of breastfeeding for mother and baby and infant needs and capabilities, including early infant feeding cues and initial attachment of the baby to the breast.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?12/13/12499?source=see_link\">",
"       \"Patient information: Labor and delivery (childbirth) (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?4/2/4131?source=see_link\">",
"       \"Patient information: How to tell when labor starts (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/5/33873?source=see_link\">",
"       \"Patient information: Managing pain during labor and delivery (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Four factors important in determining a woman's satisfaction with her childbirth experience are personal expectations, the amount of support she receives, the quality of the caregiver-patient relationship, and her involvement in decision making. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The goals of childbirth education are to enable women to labor and give birth confidently, comfortably, and supported by the people around them. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Goals of preparation for labor and birth'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Childbirth education helps prospective parents prepare for childbirth and parenthood by providing information on issues such as maternity care practices, pain relief, decision making during labor, infant and postnatal care, and breastfeeding. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'What women need to know'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6\">",
"       'What to do to prepare'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Childbirth education classes are a good way to prepare for birth. They provide an opportunity to meet with other pregnant women, share stories, obtain knowledge about",
"      <span class=\"nowrap\">",
"       pregnancy/labor/birth/postpartum",
"      </span>",
"      issues, address fears and concerns, and devote time to focusing on preparing for birth. This information helps women know what to expect during labor and birth, and provides a forum for ultimately making choices within the context of modern maternity care and developing a personal plan for birth. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Childbirth education'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Typically, a written birth plan covers items listed in the table (",
"      <a class=\"graphic graphic_table graphicRef79039 \" href=\"UTD.htm?7/0/7180\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Birth plans'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/1\">",
"      Simkin P. The experience of maternity in a woman's life. J Obstet Gynecol Neonatal Nurs 1996; 25:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/2\">",
"      Simkin P. Just another day in a woman's life? Part II: Nature and consistency of women's long-term memories of their first birth experiences. Birth 1992; 19:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/3\">",
"      Hodnett ED. Pain and women's satisfaction with the experience of childbirth: a systematic review. Am J Obstet Gynecol 2002; 186:S160.",
"     </a>",
"    </li>",
"    <li>",
"     Ondek M. Historical development. In: Childbirth education: Practice, research, and theory, Nichol F, Humenick S (Eds) (Eds), WB Saunders, Philadelphia 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/5\">",
"      Zwelling E. Childbirth education in the 1990s and beyond. J Obstet Gynecol Neonatal Nurs 1996; 25:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/6\">",
"      Lothian, J. The power of pain. J Perinat Educ 1999; 8:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/7\">",
"      Simkin P. Reducing pain and enhancing progress in labor: a guide to nonpharmacologic methods for maternity caregivers. Birth 1995; 22:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/8\">",
"      Kennell J, Klaus M, McGrath S, et al. Continuous emotional support during labor in a US hospital. A randomized controlled trial. JAMA 1991; 265:2197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/9\">",
"      Scott KD, Berkowitz G, Klaus M. A comparison of intermittent and continuous support during labor: a meta-analysis. Am J Obstet Gynecol 1999; 180:1054.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/10\">",
"      Hodnett ED, Gates S, Hofmeyr GJ, Sakala C. Continuous support for women during childbirth. Cochrane Database Syst Rev 2007; :CD003766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/11\">",
"      Bloom SL, Casey BM, Schaffer JI, et al. A randomized trial of coached versus uncoached maternal pushing during the second stage of labor. Am J Obstet Gynecol 2006; 194:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/12\">",
"      Roberts JE, Mendez-Bauer C, Wodell DA. The effects of maternal position on uterine contractility and efficiency. Birth 1983; 10:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/13\">",
"      Gupta JK, Hofmeyr GJ, Shehmar M. Position in the second stage of labour for women without epidural anaesthesia. Cochrane Database Syst Rev 2012; 5:CD002006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/14\">",
"      Lothian, J. Birth plans: the good, the bad and the future. J Obstet Gynecol Neonatal Nurs 2006; 35:1.",
"     </a>",
"    </li>",
"    <li>",
"     Lothian, J, DeVries, C. The Official Lamaze Guide: giving birth with confidence. Meadowbrook Press, Minneapolis, MN 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/16\">",
"      Lowe NK. The nature of labor pain. Am J Obstet Gynecol 2002; 186:S16.",
"     </a>",
"    </li>",
"    <li>",
"     Lamaze International Promoting. Safe, Healthy Birth Practices 2009. Lamaze International, Washington DC.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/18\">",
"      Romano AM, Lothian JA. Promoting, protecting, and supporting normal birth: a look at the evidence. J Obstet Gynecol Neonatal Nurs 2008; 37:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/19\">",
"      Bonovich L. Recognizing the onset of labor. J Obstet Gynecol Neonatal Nurs 1990; 19:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/20\">",
"      Kistin N, Benton D, Rao S, Sullivan M. Breast-feeding rates among black urban low-income women: effect of prenatal education. Pediatrics 1990; 86:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/21\">",
"      Maimburg RD, Vaeth M, D&uuml;rr J, et al. Randomised trial of structured antenatal training sessions to improve the birth process. BJOG 2010; 117:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/22\">",
"      Gagnon AJ, Sandall J. Individual or group antenatal education for childbirth or parenthood, or both. Cochrane Database Syst Rev 2007; :CD002869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/23\">",
"      Bergstr&ouml;m M, Kieler H, Waldenstr&ouml;m U. Effects of natural childbirth preparation versus standard antenatal education on epidural rates, experience of childbirth and parental stress in mothers and fathers: a randomised controlled multicentre trial. BJOG 2009; 116:1167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/24\">",
"      Hodnett ED, Downe S, Walsh D, Weston J. Alternative versus conventional institutional settings for birth. Cochrane Database Syst Rev 2010; :CD000012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/25\">",
"      Savage JS. Birth stories: a way of knowing in childbirth education. J Perinat Educ 2001; 10:3.",
"     </a>",
"    </li>",
"    <li>",
"     Celebrate Birth. Injoy Videos. Boulder, Colorado. 2000.",
"    </li>",
"    <li>",
"     Open Minds To Birth. Vida Health Communications. Boston, 2002.",
"    </li>",
"    <li>",
"     England, P, Horowitz, R. Birthing from Within. Partera Press, Alburquerque, NM, 1998.",
"    </li>",
"    <li>",
"     Gaskin, IM. Ina May's Guide to Childbirth. Bantam Books, New York 2003.",
"    </li>",
"    <li>",
"     Boston Women's Health Collective and Judy Norsegian, 2008.",
"    </li>",
"    <li>",
"     Penny Simkin, Harvard Common Press, Boston 2007.",
"    </li>",
"    <li>",
"     Simkin, P, Ancheta, R, et al. The labor progress handbook. Blackwell Science Press, Malden MA 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/33\">",
"      Adams SS, Eberhard-Gran M, Eskild A. Fear of childbirth and duration of labour: a study of 2206 women with intended vaginal delivery. BJOG 2012; 119:1238.",
"     </a>",
"    </li>",
"    <li>",
"     Dick-Read, G. Natural childbirth. Heinemann, 1933.",
"    </li>",
"    <li>",
"     Lamaze, F. Painless childbirth. Psychoprophylactic method. Burke, London, 1958.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/36\">",
"      Lothian JA. Safe, healthy birth: what every pregnant woman needs to know. J Perinat Educ 2009; 18:48.",
"     </a>",
"    </li>",
"    <li>",
"     Balaskas, J. Active birth: The new approach to giving birth naturally. Harvard Common Press, 1992.",
"    </li>",
"    <li>",
"     Mongan, M. Hypnobirthing: The breakthrough natural approach to safer, easier, more comfortable birthing. Health Communications Inc 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/39\">",
"      Lothian, J. Why become certified? J Perinat Educ 1996; 5:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/40\">",
"      Lothian, J. How large is too large: optimal childbirth class size. J Perinat Educ 1992; 1:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/41\">",
"      De Vries CA, De Vries RG. Childbirth education in the 21st century: an immodest proposal. J Perinat Educ 2007; 16:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10311/abstract/42\">",
"      Lothian JA. Childbirth education at the crossroads. J Perinat Educ 2008; 17:45.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4470 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-190.92.87.104-BD5B12EED9-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_4_10311=[""].join("\n");
var outline_f10_4_10311=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GOALS OF PREPARATION FOR LABOR AND BIRTH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Coping with pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      WHAT WOMEN NEED TO KNOW",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Support during labor and delivery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      WHAT TO DO TO PREPARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Childbirth education",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Birth plans",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      WHAT TO LOOK FOR IN A PREPARATION FOR CHILDBIRTH CLASS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/4470\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/4470|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/0/7180\" title=\"table 1\">",
"      Topics in a birth plan",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/20/22855?source=related_link\">",
"      Continuous intrapartum support",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/2/4131?source=related_link\">",
"      Patient information: How to tell when labor starts (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?12/13/12499?source=related_link\">",
"      Patient information: Labor and delivery (childbirth) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/5/33873?source=related_link\">",
"      Patient information: Managing pain during labor and delivery (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_4_10312="Suppurative thyroiditis in children and adolescents";
var content_f10_4_10312=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Suppurative thyroiditis in children and adolescents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/4/10312/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/4/10312/contributors\">",
"     Itzhak Brook, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/4/10312/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/4/10312/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/4/10312/contributors\">",
"     Mitchell Geffner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/4/10312/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/4/10312/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/4/10312/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Suppurative thyroiditis (ST) is caused by an infection of the thyroid gland (usually bacterial), and is rare, but potentially life-threatening [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The disease is far less common than other inflammatory conditions of the thyroid gland, including subacute granulomatous thyroiditis (which results from a viral infection of the gland) and chronic thyroiditis (which is usually autoimmune in nature). The signs and symptoms of ST may mimic these and other noninfectious inflammatory conditions. Recognition of the clinical and bacteriological features of ST is essential for prompt management.",
"   </p>",
"   <p>",
"    The primary treatment for ST is antimicrobial therapy, directed against the likely bacterial pathogens. Although most cases of ST are caused by aerobic bacteria, anaerobic bacteria are increasingly recognized as a cause of ST, and this has led to revision of treatment protocols for this condition. Rarely, mycobacteria, fungi, or other nonbacterial pathogens may cause a subacute form of suppurative thyroiditis.",
"   </p>",
"   <p>",
"    The pathogenesis, diagnosis, and treatment of acute suppurative thyroiditis in children are discussed here; subacute forms of suppurative thyroiditis are discussed briefly. The diagnosis and treatment of other inflammatory conditions of the thyroid gland, including subacute granulomatous thyroiditis and chronic thyroiditis, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/29/7641?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical manifestations and diagnosis of hyperthyroidism in children and adolescents\", section on 'Differential diagnosis of thyrotoxicosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43830?source=see_link&amp;anchor=H4#H4\">",
"     \"Overview of thyroiditis\", section on 'Subacute thyroiditis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/22/21865?source=see_link&amp;anchor=H4#H4\">",
"     \"Acquired hypothyroidism in childhood and adolescence\", section on 'Chronic autoimmune thyroiditis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The thyroid gland is relatively resistant to infections [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/3\">",
"     3",
"    </a>",
"    ]. The rarity of thyroid infection has been explained by the high concentration of iodine within the gland, ample supply of blood and lymphatics, and the anatomical isolation of the gland from other neck structures. This isolation is due to the capsule around the thyroid gland and the lack of direct communication with neighboring structures. All of these features make the thyroid gland relatively resistant to infection by direct extension from contiguous sites [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8659811\">",
"    <span class=\"h2\">",
"     Pyriform sinus fistula",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children, a fistula from the pyriform sinus associated with a third or fourth branchial arch anomaly [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/4\">",
"     4",
"    </a>",
"    ] is a common route through which bacteria infect the thyroid gland (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef76834 \" href=\"UTD.htm?35/9/35999\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. This type of fistula extends from the pharynx to the thyroid capsule and is almost always left-sided; the anomaly is particularly likely to be found in children with recurrent or left-sided ST. For a child with a pyriform sinus fistula presenting with a first episode of suppurative thyroiditis, the risk of recurrent thyroiditis has not been established, but appears to be high [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/5,8-10\">",
"     5,8-10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Other predisposing conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other routes through which the thyroid may become infected include a thyroglossal duct remnant [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/11\">",
"     11",
"    </a>",
"    ], congenital branchial fistula [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/12\">",
"     12",
"    </a>",
"    ], hematogenous spread [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/13,14\">",
"     13,14",
"    </a>",
"    ], direct spread from a adjacent site [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/15\">",
"     15",
"    </a>",
"    ], or perforated esophagus [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/16\">",
"     16",
"    </a>",
"    ]. In reports of adults with suppurative thyroiditis, a previously diseased area of the thyroid, such as goiter or adenomas, is a common finding [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/2,14\">",
"     2,14",
"    </a>",
"    ]. In other series of adults with suppurative thyroiditis, approximately one quarter of the patients were immunocompromised; half of these had HIV [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. A case report has described suppurative thyroiditis as a presenting feature of juvenile systemic lupus erythematosus [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/19\">",
"     19",
"    </a>",
"    ]. Most fungal infections are found in diabetic and immunocompromised individuals (mostly HIV and leukemia).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The organisms most often isolated from ST in children are Staphylococcus aureus, Streptococcus pyogenes, Staphylococcus epidermidis, and Streptococcus pneumoniae, in descending order of frequency [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/1,2,17,20-22\">",
"     1,2,17,20-22",
"    </a>",
"    ]. The prevalence of infection with methicillin-resistant Staphylococcus aureus (MRSA) is increasing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/23\">",
"     23",
"    </a>",
"    ]. Other aerobic bacteria are Klebsiella species [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/24\">",
"     24",
"    </a>",
"    ], Haemophilus influenzae, Streptococcus viridans, Eikenella corrodens, Salmonella species, and Enterobacteriaceae [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When anaerobic bacteria are isolated from the infected thyroid they tend to be members of the oropharyngeal flora, and may spread to the gland in a similar fashion as the aerobic pathogens of similar origin [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/1,2,11,13-15,17,20,26\">",
"     1,2,11,13-15,17,20,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The frequency of infection with anaerobic bacteria in ST is unknown because adequate methodologies for the recovery of anaerobic bacteria were not uniformly employed in all past studies. One report described two children with recurrent episodes of acute ST [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/26\">",
"     26",
"    </a>",
"    ]. Anaerobic Gram-negative bacilli and Peptostreptococcus species were recovered from these patients' infected thyroid glands. Gram-negative anaerobic bacilli (eg, Prevotella, Porphyromonas, and Fusobacteria) are increasingly recognized as a cause of ST, and a growing number of strains are penicillin-resistant. These resistant organisms are particularly common among patients recently treated with penicillin, due to induction of beta-lactamase [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/27\">",
"     27",
"    </a>",
"    ]. Eikenella corrodens and Actinomyces species have also been reported in several studies [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/2,26,28\">",
"     2,26,28",
"    </a>",
"    ]. Polymicrobial infection (two to five organisms per abscess) was present in about 30 percent of the patients [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/5\">",
"     5",
"    </a>",
"    ]. The recovery of anaerobes in ST has also been associated with post-abortal sepsis, subphrenic abscess, pilonidal abscess, urinary tract infection, and perforation of the esophagus [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/1,2,17,20\">",
"     1,2,17,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Organisms that are rarely recovered from patients with ST, which can cause chronic or insidious infection, especially in patients with HIV disease, include Mycobacterium tuberculosis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/21\">",
"     21",
"    </a>",
"    ], atypical mycobacteria, Aspergillus species, Coccidioides immitis, Cryptococcus neoformans, Histoplasma capsulatum, Candida species, Treponema pallidum, Echinococcus species, and Pneumocystis carinii [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/1,2,17,20\">",
"     1,2,17,20",
"    </a>",
"    ]. P. carinii thyroiditis is found almost exclusively in patients with HIV [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/18\">",
"     18",
"    </a>",
"    ] or in those with underlying malignancy. Rarely, the thyroid is involved in disseminated strongyloidiasis, and cysticercosis.",
"   </p>",
"   <p>",
"    Viruses have been associated with thyroiditis, but these tend to cause a subacute form. Viruses that have been implicated in this disorder include measles, influenza, enterovirus, Epstein-Barr, adenovirus, cytomegalovirus, echovirus, mumps, and St. Louis encephalitis viruses. Other implicated infections include malaria, Q fever, and the cat-scratch disease agent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43830?source=see_link&amp;anchor=H4#H4\">",
"     \"Overview of thyroiditis\", section on 'Subacute thyroiditis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most cases of acute ST present with a sudden onset of pain, and firm, tender, red, warm swelling in the anterior aspect of the neck that moves on swallowing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/2\">",
"     2",
"    </a>",
"    ]. There may be associated fever, chills, local warmth, erythema, hoarseness, sore throat, dysphagia, and dysphonia. The symptoms develop over days to a few weeks. Many cases arise shortly after an apparent upper respiratory tract infection or pharyngitis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/5\">",
"     5",
"    </a>",
"    ]. Neck pain often is unilateral and radiates to the mandible, ears, or occiput. Neck flexion reduces the severity of the pain. The pain worsens with neck hyperextension. Other signs that are related to pressure upon the neck muscle include involuntary depression of the chin upon swallowing and limitation of cervical extension.",
"   </p>",
"   <p>",
"    Symptoms of ST may be present from days to months (mean 18 days) prior to the establishment of diagnosis. Symptoms in those with tuberculous thyroiditis are present for a mean interval of 105 days (range, 14 days to 1 year).",
"   </p>",
"   <p>",
"    On examination, the thyroid gland is swollen and tender. A single lobe, both lobes, or only the isthmus of the thyroid may be involved, so that the swelling and tenderness may be bilateral or unilateral. In one series of ST in children, the infection preferentially involved the left lobe in 90 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/5\">",
"     5",
"    </a>",
"    ]. Rarely, a thyroid abscess can be manifested as a pulsatile mass. Erythema develops over the gland, and regional lymphadenopathy may be present as the disease progresses. Fluctuance may develop later, if an abscess forms.",
"   </p>",
"   <p>",
"    Pain, fever, and tenderness are less often observed in patients with tuberculous thyroiditis as compared to those with acute bacterial infection. The diagnosis of fungal and parasitic thyroiditis is generally first made at surgery. P. carinii thyroiditis has no specific clinical features except that most individuals suffer from HIV and present with a diffuse tender goiter [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;ST should be differentiated from other more common thyroid conditions such as adenoma, goiter, or subacute granulomatous thyroiditis. Making this distinction can be difficult, particularly early in the course of the disease. As compared to acute ST, subacute granulomatous thyroiditis may present with identical local signs, but systemic manifestations are less severe. Subacute thyroiditis usually subsides over time, whereas untreated acute ST generally results in increasing toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/5,30\">",
"     5,30",
"    </a>",
"    ]. Other conditions that should be differentiated from ST are intracystic hemorrhage, malignancy, and (rarely) painful Hashimoto's thyroiditis. Thyroid malignancy can present as ST [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43830?source=see_link&amp;anchor=H4#H4\">",
"     \"Overview of thyroiditis\", section on 'Subacute thyroiditis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/22/21865?source=see_link&amp;anchor=H4#H4\">",
"     \"Acquired hypothyroidism in childhood and adolescence\", section on 'Chronic autoimmune thyroiditis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Symptoms of neck pain resembling ST may occur in children with cervical lymphadenitis, although the tenderness is less likely to be localized to the thyroid. The differential diagnosis and evaluation of the child with prominent lymphadenitis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/17/24857?source=see_link\">",
"     \"Diagnostic approach to and initial treatment of cervical lymphadenitis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Laboratory testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of ST can be supported by laboratory investigations. The serum thyroxine (T4), triiodothyronine (T3), and thyroid-stimulating hormone (TSH) are generally normal. In a series of children with thyroiditis, 93 percent had normal thyroid function tests, 4 percent were slightly hyperthyroid, and 2 percent were slightly hypothyroid [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/5\">",
"     5",
"    </a>",
"    ]. Thyroid function depends in part on the etiology and time course of the thyroiditis. In a series of adults with ST, 83 percent of patients with bacterial thyroiditis had normal thyroid function tests [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/17\">",
"     17",
"    </a>",
"    ]. By contrast, patients with fungal thyroiditis were likely to be hypothyroid (62 percent), and those with mycobacterial infections were most likely to be hyperthyroid (50 percent). Hypothyroidism also has been reported in several patients with P. carinii infection of the thyroid, in association with HIV disease [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/29,32,33\">",
"     29,32,33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Leukocytosis, an elevated erythrocyte sedimentation rate, and elevated C-reactive protein are usually present in acute bacterial thyroiditis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/5\">",
"     5",
"    </a>",
"    ]. An elevated erythrocyte sedimentation rate is also seen in subacute granulomatous thyroiditis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest evaluating patients with suspected ST with an ultrasound of the neck. In ST, the ultrasound often reveals unilobular swelling",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    abscess formation. These findings assist in the differentiation of ST from other causes of anterior neck pain and fever. Sonography of acute&nbsp;suppurative thyroiditis generally reveals a unifocal perithyroidal hypoechoic space, and an effacement of the plane between the thyroid and perithyroid tissues. Atrophy and an unclear hypoechoic or low-density area in and around the affected lobe are observed in the late inflammatory stage [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/34\">",
"     34",
"    </a>",
"    ]. Sonography also is helpful in detecting spread to contiguous structures, in defining the anatomy if surgical exploration is planned, and allows radiographically-guided drainage of a thyroid abscess if present [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Differential diagnosis'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H11\">",
"     'Culture'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Computed tomography imaging (CT) and magnetic resonance imaging (MRI) scans of the neck are generally not needed unless the ultrasound fails to establish the diagnosis, or if the clinical course suggests extension of a thyroid abscess to other locations such as the mediastinum. Like ultrasonography, CT may be used to exclude the possibility of cervical abscess outside the thyroid capsule.",
"   </p>",
"   <p>",
"    We also suggest performing lateral soft tissue radiographs of the neck. In ST, these may show evidence of tissue edema, and the tracheal air column may be deviated or compressed. Plain radiographs can be useful in detecting free gas in the tissues produced by gas-forming bacteria, or the presence of calcifications associated with Echinococcus or Pneumocystis infection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/37\">",
"     37",
"    </a>",
"    ]. The presence of soft-tissue gas",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    foul-smelling pus suggests the presence of an anaerobic infection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A radionuclide thyroid scan is not necessary for the diagnosis of ST except in cases in which the diagnosis is unclear. When performed, it often shows absent or decreased uptake, with a patchy uptake or a cold area in the affected thyroid lobe [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/5,26\">",
"     5,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3473668\">",
"    <span class=\"h3\">",
"     Evaluation for pyriform sinus fistula",
"    </span>",
"    &nbsp;&mdash;&nbsp;For all children with recurrent or left-sided thyroiditis, we recommend a careful evaluation for a pyriform sinus fistula. We also suggest this evaluation for other children with unexplained ST (ie, those presenting with their first episode and without left-sided disease), as up to 70 percent will have a pyriform sinus fistula [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8659811\">",
"     'Pyriform sinus fistula'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Pyriform sinus fistula may be identified by a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    swallow study (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef76834 \" href=\"UTD.htm?35/9/35999\">",
"     image 1",
"    </a>",
"    ) or direct laryngoscopy of the hypopharynx; direct laryngoscopy appears to be somewhat more sensitive [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/5-9,38\">",
"     5-9,38",
"    </a>",
"    ]. In children with a pyriform sinus fistula, thyroid ultrasonography performed after recovery from ST may show a newly developed echogenic tract, which has been called the &ldquo;emerging echogenic tract sign&rdquo; [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/39\">",
"     39",
"    </a>",
"    ]. Patients with this finding should be carefully re-evaluated for a pyriform sinus fistula using a barium swallow or direct laryngoscopy. &nbsp; &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the lesion is fluctuant or if there is sonographic evidence of an abscess, this should be aspirated if possible or surgically drained if indicated. Specimens should be obtained for Gram stain to assist in the diagnosis and choice of proper antimicrobial therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/1,30\">",
"     1,30",
"    </a>",
"    ]. The aspirate should be cultured for aerobic and anaerobic bacteria, fungi, and mycobacteria. Gram and acid-fast stains should be performed, but a negative Gram stain does not exclude bacterial infection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Other tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient should be tested for tuberculosis using an intradermal skin test. Atypical mycobacteria infection also should be considered, particularly in immunocompromised children or those with prominent lymphadenitis. The differential diagnosis and evaluation for children with lymphadenitis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/53/13143?source=see_link\">",
"     \"Latent tuberculosis infection in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23625?source=see_link\">",
"     \"Tuberculosis disease in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/17/24857?source=see_link\">",
"     \"Diagnostic approach to and initial treatment of cervical lymphadenitis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute ST is rare in children, with fewer than 100 cases reported in the literature. Thus, the following recommendations for diagnosis and management are based on outcomes of several small series of cases, and by analogous experience with the management of other suppurative infections of the head and neck [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;ST requires immediate parenteral antibiotic therapy before abscess formation begins. If fluctuation or sonographic evidence of an abscess is present, surgical drainage is generally necessary in addition to antibiotic therapy.",
"   </p>",
"   <p>",
"    For patients without fluctuance or sonographic evidence of abscess formation, antimicrobial therapy is begun empirically. Because of the wide range of different bacteria that can cause bacterial thyroiditis, antibiotics with a broad antimicrobial spectrum are indicated, at least until culture results are available. Most patients should be treated parenterally, particularly if there is any evidence of toxicity. Antibiotics should be selected to provide adequate coverage for S. aureus and S. pyogenes, as well as penicillin-resistant anaerobic gram-negative bacilli and Peptostreptococcus. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Microbiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Each of the following regimens provides appropriate broad-spectrum coverage for the organisms likely to cause acute ST and is appropriate for initial empiric therapy:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"       Clindamycin",
"      </a>",
"     </li>",
"     <li>",
"      A penicillin with a beta-lactamase inhibitor (eg,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"       ampicillin",
"      </a>",
"      with sulbactam or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/10/33956?source=see_link\">",
"       piperacillin",
"      </a>",
"      with tazobactam)",
"     </li>",
"     <li>",
"      A carbapenem (imipenem or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/24/2439?source=see_link\">",
"       meropenem",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/59/21425?source=see_link\">",
"       Metronidazole",
"      </a>",
"      with either a macrolide or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/49/34583?source=see_link\">",
"       amoxicillin",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If no clinical improvement occurs after 36 to 48 hours of therapy, a reassessment of therapy is needed.",
"   </p>",
"   <p>",
"    For very mild disease or after substantial clinical improvement, treatment with oral antibiotics may be possible. Appropriate oral antibiotics include penicillinase-resistant penicillins such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/45/31446?source=see_link\">",
"     cloxacillin",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/61/17363?source=see_link\">",
"     dicloxacillin",
"    </a>",
"    , the combination of a penicillin and a beta-lactamase inhibitor (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/49/34583?source=see_link\">",
"     amoxicillin",
"    </a>",
"    with clavulanate), or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"     clindamycin",
"    </a>",
"    . Treatment should be administered for at least 14 days.",
"   </p>",
"   <p>",
"    For patients with an abscess that can be aspirated, the selection of empiric antibiotic therapy can be guided initially by the results of a Gram stain of the aspirated pus. The antibiotic regimen is then adjusted based on the results of the culture and sensitivity testing. For infections with methicillin-susceptible S. aureus, the preferred drug is a beta-lactamase-resistant penicillin. Alternatives are the cephalosporins and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"     clindamycin",
"    </a>",
"    . Treatment of methicillin-resistant S. aureus (MRSA) infections is discussed separately [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/6/29802?source=see_link&amp;anchor=H11#H11\">",
"     \"Treatment of invasive methicillin-resistant Staphylococcus aureus infection in children\", section on 'Treatment approach'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33290?source=see_link&amp;anchor=H10#H10\">",
"     \"Evaluation and management of suspected methicillin-resistant Staphylococcus aureus skin and soft tissue infections in children\", section on 'Approach for children &gt;30 days of age'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery may be needed to drain the infection and to repair any developmental abnormality that led to the development of ST, such as a fistula from a pyriform sinus or thyroglossal duct remnant. Drainage should be carried out if clinical examination or radiographic findings by",
"    <span class=\"nowrap\">",
"     ultrasound/CT",
"    </span>",
"    scan suggest an abscess or if there is evidence of gas formation. If extensive necrosis develops, or if the infection persists despite adequate antibiotics (as evidenced by leukocytosis, continued fever, and progressive signs of local inflammation), thyroid lobectomy may be needed [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/1,5,30,35\">",
"     1,5,30,35",
"    </a>",
"    ]. In this case, debridement of necrotic tissue should be performed, and the wound allowed to heal by secondary intention.",
"   </p>",
"   <p>",
"    Management of the predisposing conditions is of great importance. Because of an apparently high risk for recurrent infections in individuals with a pyriform sinus fistula or thyroglossal duct remnant, most authors recommend obliteration of these structures if present [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/5-9\">",
"     5-9",
"    </a>",
"    ]. Earlier series describe surgical excision of the fistula. This procedure was generally successful but has some risk for injury to the recurrent laryngeal nerve [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. More recently, several small case series report management of the fistula using endoscopic cauterization, with successful obliteration of the fistula in most cases [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/8,9,38\">",
"     8,9,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients should also be evaluated and treated for preexisting thyroid pathology, such as goiter and adenomas.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prognosis following appropriate medical and surgical therapy for ST is generally excellent. The recovery is usually complete, and any abnormalities of thyroid function typically resolve after treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/1,5,30\">",
"     1,5,30",
"    </a>",
"    ]. L-thyroxine replacement therapy may be needed in those with transient or prolonged hypothyroidism, which is most likely to occur in individuals with severe, diffuse inflammation and necrosis of the gland.",
"   </p>",
"   <p>",
"    In a subset of patients, ST is caused by an occult pyriform sinus fistula, and these patients are at risk for recurrent ST unless that fistula is identified and surgically closed. The fistula can develop a tract to the cervical neck skin [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8659811\">",
"     'Pyriform sinus fistula'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H3473668\">",
"     'Evaluation for pyriform sinus fistula'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Local complications are rare and include extension of the infection into adjacent sites and organs (anterior mediastinum, trachea, and esophagus), disruption of regional sympathetic nerves and paralysis of the vocal cords, thrombosis of the internal jugular vein (Lemierre's syndrome), descending necrotizing mediastinitis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/42\">",
"     42",
"    </a>",
"    ], and extrinsic compression of the trachea [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/43\">",
"     43",
"    </a>",
"    ]. Rheumatic fever has been described following group A beta-hemolytic streptococcal thyroiditis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10312/abstract/44\">",
"     44",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Local and systemic complications may be life-threatening, especially if therapy is postponed or is inadequate. Potential causes of death include pneumonia, tracheal obstruction or perforation, metastatic infection, and rupture of a thyroid abscess causing mediastinitis, pericarditis, or sepsis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute suppurative thyroiditis is caused by bacterial infection of the thyroid gland. The condition is rare, but potentially life-threatening. Most patients have predisposing conditions. Pyriform sinus fistulas are present in up to 70 percent of children with acute suppurative thyroiditis. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathogenesis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8659811\">",
"       'Pyriform sinus fistula'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Subacute forms of suppurative thyroiditis may be caused by infections with mycobacteria or fungi, particularly in immunocompromised patients. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children generally present with the acute onset of pain and tender swelling in the anterior aspect of the neck that develops over days to a few weeks, often associated with fever and leukocytosis. The infection preferentially involves the left lobe in 90 percent of cases, but may be bilateral. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Thyroid function tests are usually normal in acute suppurative thyroiditis, but hypothyroidism or hyperthyroidism may develop in patients with a subacute course. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Laboratory testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with suspected suppurative thyroiditis should be evaluated with ultrasonography. This will assess for abscess formation and for possible extension of the infection into adjacent structures. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All children with recurrent or left-sided acute suppurative thyroiditis should be evaluated for a possible pyriform sinus fistula, using a",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      esophagram or direct laryngoscopy (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef76834 \" href=\"UTD.htm?35/9/35999\">",
"       image 1",
"      </a>",
"      ). We also suggest this evaluation for children presenting with their first episode of thyroiditis or bilateral involvement of the thyroid. (See",
"      <a class=\"local\" href=\"#H3473668\">",
"       'Evaluation for pyriform sinus fistula'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If there is clinical or sonographic evidence of abscess formation, we recommend needle aspiration of the mass for culture. The specimen should be stained and cultured for aerobic and anaerobic bacteria, fungi, and mycobacteria. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Culture'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All patients with presumed suppurative thyroiditis should be treated promptly with antibiotics. For initial empiric therapy, we suggest a regimen that provides coverage for aerobic and anaerobic mouth organisms including S. aureus, S. pyogenes, gram-negative anaerobic bacilli, and Peptostreptococcus (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Appropriate antibiotic regimens include",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"       clindamycin",
"      </a>",
"      alone, or the combination of penicillin and a beta-lactamase inhibitor, or the combination of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/59/21425?source=see_link\">",
"       metronidazole",
"      </a>",
"      and a macrolide. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Antibiotics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In cases where an abscess forms, surgical drainage may be necessary. For children with a pyriform sinus fistula, we suggest obliteration of the fistulous tract, using surgical excision or endoscopic cauterization (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Surgery'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/1\">",
"      Shah SS, Baum SG. Diagnosis and Management of Infectious Thyroiditis. Curr Infect Dis Rep 2000; 2:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/2\">",
"      Paes JE, Burman KD, Cohen J, et al. Acute bacterial suppurative thyroiditis: a clinical review and expert opinion. Thyroid 2010; 20:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/3\">",
"      Nishiyama RH. Overview of surgical pathology of the thyroid gland. World J Surg 2000; 24:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/4\">",
"      Yolmo D, Madana J, Kalaiarasi R, et al. Retrospective case review of pyriform sinus fistulae of third branchial arch origin commonly presenting as acute suppurative thyroiditis in children. J Laryngol Otol 2012; 126:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/5\">",
"      Rich EJ, Mendelman PM. Acute suppurative thyroiditis in pediatric patients. Pediatr Infect Dis J 1987; 6:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/6\">",
"      Sai Prasad TR, Chong CL, Mani A, et al. Acute suppurative thyroiditis in children secondary to pyriform sinus fistula. Pediatr Surg Int 2007; 23:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/7\">",
"      Miyauchi A, Matsuzuka F, Kuma K, Takai S. Piriform sinus fistula: an underlying abnormality common in patients with acute suppurative thyroiditis. World J Surg 1990; 14:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/8\">",
"      Pereira KD, Davies JN. Piriform sinus tracts in children. Arch Otolaryngol Head Neck Surg 2006; 132:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/9\">",
"      Miyauchi A, Inoue H, Tomoda C, Amino N. Evaluation of chemocauterization treatment for obliteration of pyriform sinus fistula as a route of infection causing acute suppurative thyroiditis. Thyroid 2009; 19:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/10\">",
"      Taphey M, Pornkul R. Acute suppurative thyroiditis due to pyriform sinus fistula: a case report. J Med Assoc Thai 2010; 93:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/11\">",
"      Bussman YC, Wong ML, Bell MJ, Santiago JV. Suppurative thyroiditis with gas formation due to mixed anaerobic infection. J Pediatr 1977; 90:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/12\">",
"      Madana J, Yolmo D, Gopalakrishnan S, Saxena SK. Complete congenital third branchial fistula with left-sided, recurrent, suppurative thyroiditis. J Laryngol Otol 2010; 124:1025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/13\">",
"      Abe K, Taguchi T, Okuno A, et al. Acute suppurative thyroiditis in children. J Pediatr 1979; 94:912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/14\">",
"      Gaafar H, El-Garem F. Acute thyroiditis with gas formation. J Laryngol Otol 1975; 89:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/15\">",
"      Higbee D. Acute thyroiditis in relation to deep infections of the neck. Ann Otol Rhinol Laryngol 1943; 52:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/16\">",
"      Yung BC, Loke TK, Fan WC, Chan JC. Acute suppurative thyroiditis due to foreign body-induced retropharyngeal abscess presented as thyrotoxicosis. Clin Nucl Med 2000; 25:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/17\">",
"      Yu EH, Ko WC, Chuang YC, Wu TJ. Suppurative Acinetobacter baumanii thyroiditis with bacteremic pneumonia: case report and review. Clin Infect Dis 1998; 27:1286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/18\">",
"      Golshan MM, McHenry CR, de Vente J, et al. Acute suppurative thyroiditis and necrosis of the thyroid gland: a rare endocrine manifestation of acquired immunodeficiency syndrome. Surgery 1997; 121:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/19\">",
"      Robazzi TC, Alves C, Mendon&ccedil;a M. Acute suppurative thyroiditis as the initial presentation of juvenile systemic lupus erythematosus. J Pediatr Endocrinol Metab 2009; 22:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/20\">",
"      Jeng LB, Lin JD, Chen MF. Acute suppurative thyroiditis: a ten-year review in a Taiwanese hospital. Scand J Infect Dis 1994; 26:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/21\">",
"      Lindsay LM, Mead CI. Tuberculosis of the thyroid gland with report of a case in a child aged three. Canad Med Assoc J 1934; 30:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/22\">",
"      Chi H, Lee YJ, Chiu NC, et al. Acute suppurative thyroiditis in children. Pediatr Infect Dis J 2002; 21:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/23\">",
"      Brook I. Role of methicillin-resistant Staphylococcus aureus in head and neck infections. J Laryngol Otol 2009; 123:1301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/24\">",
"      Adeyemo A, Adeosun A, Adedapo K. Unusual cause of thyroid abscess. Afr Health Sci 2010; 10:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/25\">",
"      Yoshino Y, Inamo Y, Fuchigami T, et al. A pediatric patient with acute suppurative thyroiditis caused by Eikenella corrodens. J Infect Chemother 2010; 16:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/26\">",
"      Abe K, Taguchi T, Okuno A, et al. Recurrent acute suppurative thyroiditis. Am J Dis Child 1978; 132:990.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/27\">",
"      Brook I. Emergence and persistence of beta-lactamase-producing bacteria in the oropharynx following penicillin treatment. Arch Otolaryngol Head Neck Surg 1988; 114:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/28\">",
"      Appelbaum PC, Cohen IT. Thyroid abscess associated with Eikenella corrodens in a 7-year-old child. Clin Pediatr (Phila) 1982; 21:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/29\">",
"      Guttler R, Singer PA, Axline SG, et al. Pneumocystis carinii thyroiditis. Report of three cases and review of the literature. Arch Intern Med 1993; 153:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/30\">",
"      Slatosky J, Shipton B, Wahba H. Thyroiditis: differential diagnosis and management. Am Fam Physician 2000; 61:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/31\">",
"      Crisafulli G, Wasniewska M, Ascenti G, et al. Acute suppurative thyroiditis disclosing diagnosis of thyroid cancer in a boy. J Endocrinol Invest 2008; 31:1137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/32\">",
"      Spitzer RD, Chan JC, Marks JB, et al. Case report: hypothyroidism due to pneumocystis carinii thyroiditis in a patient with acquired immunodeficiency syndrome. Am J Med Sci 1991; 302:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/33\">",
"      Battan R, Mariuz P, Raviglione MC, et al. Pneumocystis carinii infection of the thyroid in a hypothyroid patient with AIDS: diagnosis by fine needle aspiration biopsy. J Clin Endocrinol Metab 1991; 72:724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/34\">",
"      Masuoka H, Miyauchi A, Tomoda C, et al. Imaging studies in sixty patients with acute suppurative thyroiditis. Thyroid 2011; 21:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/35\">",
"      Naik KS, Bury RF. Imaging the thyroid. Clin Radiol 1998; 53:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/36\">",
"      Chang YW, Hong HS, Choi DL. Sonography of the pediatric thyroid: a pictorial essay. J Clin Ultrasound 2009; 37:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/37\">",
"      McCarty M, Coker R, Claydon E. Case report: disseminated Pneumocystis carinii infection in a patient with the acquired immune deficiency syndrome causing thyroid gland calcification and hypothyroidism. Clin Radiol 1992; 45:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/38\">",
"      Jordan JA, Graves JE, Manning SC, et al. Endoscopic cauterization for treatment of fourth branchial cleft sinuses. Arch Otolaryngol Head Neck Surg 1998; 124:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/39\">",
"      Park NH, Park HJ, Park CS, et al. The emerging echogenic tract sign of pyriform sinus fistula: an early indicator in the recovery stage of acute suppurative thyroiditis. AJNR Am J Neuroradiol 2011; 32:E44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/40\">",
"      Smith SL, Pereira KD. Suppurative thyroiditis in children: a management algorithm. Pediatr Emerg Care 2008; 24:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/41\">",
"      Madana J, Yolmo D, Gopalakrishnan S, Saxena SK. Cervical infection secondary to pyriform sinus fistula of branchial origin. Congenit Anom (Kyoto) 2009; 49:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/42\">",
"      Pereira O, Prasad DS, Bal AM, et al. Fatal descending necrotizing mediastinitis secondary to acute suppurative thyroiditis developing in an apparently healthy woman. Thyroid 2010; 20:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/43\">",
"      Lough DR, Ramadan HH, Aronoff SC. Acute suppurative thyroiditis in children. Otolaryngol Head Neck Surg 1996; 114:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10312/abstract/44\">",
"      Sultany GL, Kahaleh MB. Acute rheumatic fever after thyroid abscess in an adult. South Med J 1983; 76:810.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5822 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-194.187.108.93-69C8FD1B77-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_4_10312=[""].join("\n");
var outline_f10_4_10312=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8659811\">",
"      Pyriform sinus fistula",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Other predisposing conditions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Laboratory testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3473668\">",
"      - Evaluation for pyriform sinus fistula",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Culture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Other tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5822\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5822|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?35/9/35999\" title=\"diagnostic image 1\">",
"      Pyriform sinus fistula",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/22/21865?source=related_link\">",
"      Acquired hypothyroidism in childhood and adolescence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/29/7641?source=related_link\">",
"      Clinical manifestations and diagnosis of hyperthyroidism in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/17/24857?source=related_link\">",
"      Diagnostic approach to and initial treatment of cervical lymphadenitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33290?source=related_link\">",
"      Evaluation and management of suspected methicillin-resistant Staphylococcus aureus skin and soft tissue infections in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/53/13143?source=related_link\">",
"      Latent tuberculosis infection in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43830?source=related_link\">",
"      Overview of thyroiditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/6/29802?source=related_link\">",
"      Treatment of invasive methicillin-resistant Staphylococcus aureus infection in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23625?source=related_link\">",
"      Tuberculosis disease in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_4_10313="Juvenile spring eruption 1";
var content_f10_4_10313=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F55229%7EDERM%2F68969&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F55229%7EDERM%2F68969&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Juvenile spring eruption",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pruritic, erythematous vesicles and crusted papules occurred on the ears of this 7-year-old boy after sun-exposure in the early spring.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Eric Ehrsam, MD, Dermatlas; file://www.dermatlas.org.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Juvenile spring eruption",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 409px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythematous papules and vesicles are present on the ear of this young girl with juvenile spring eruption.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Bernard Cohen, MD, Dermatlas; file://www.dermatlas.org.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_4_10313=[""].join("\n");
var outline_f10_4_10313=null;
var title_f10_4_10314="Preoperative medical evaluation of the healthy patient";
var content_f10_4_10314=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Preoperative medical evaluation of the healthy patient",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/4/10314/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/4/10314/contributors\">",
"     Gerald W Smetana, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/4/10314/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/4/10314/contributors\">",
"     Mark D Aronson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/4/10314/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/4/10314/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/4/10314/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians are often asked to evaluate a patient prior to surgery. The medical consultant may be seeing the patient at the request of the surgeon, or may be the primary care clinician assessing the patient prior to consideration of a surgical referral. The goal of the evaluation of the healthy patient is to detect unrecognized disease and risk factors that may increase the risk of surgery above baseline and to propose strategies to reduce this risk.",
"   </p>",
"   <p>",
"    The evaluation of healthy patients prior to surgery is reviewed here. Preoperative assessments for specific systems issues and surgical procedures are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=see_link\">",
"     \"Estimation of cardiac risk prior to noncardiac surgery\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/45/40666?source=see_link\">",
"     \"Perioperative medication management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/48/41735?source=see_link\">",
"     \"Overview of the principles of medical consultation and perioperative medicine\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/8/1162?source=see_link\">",
"     \"Evaluation of preoperative pulmonary risk\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     RATIONALE FOR SELECTIVE TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of unrecognized disease that influences surgical risk is low in healthy individuals. Nevertheless, clinicians often perform laboratory tests in this group of patients out of habit and medicolegal concern, with little benefit and a high incidence of false positive results. Representative studies that have addressed this issue include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a trial of 1061 ambulatory surgical patients randomly assigned to preoperative testing or no testing, there was no difference in perioperative adverse events or events within 30 days of ambulatory surgery [",
"      <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/1\">",
"       1",
"      </a>",
"      ]. Patients assigned to testing could receive a complete blood count, electrolytes, blood glucose, creatinine, electrocardiogram,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      chest radiograph, based on the Ontario Preoperative Testing Grid.",
"     </li>",
"     <li>",
"      Medical consultants commonly see patients before planned cataract surgery. In many institutions, guidelines still require routine laboratory testing despite compelling evidence showing no benefit of such testing. A systematic review of three randomized trials of testing versus no testing in a total of 21,531 cataract surgeries found that adverse events did not differ between the two groups [",
"      <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/2\">",
"       2",
"      </a>",
"      ]. Institutions may safely eliminate a requirement for routine laboratory tests before cataract surgery.",
"     </li>",
"     <li>",
"      In a retrospective study of 2000 patients undergoing elective surgery, 60 percent of routinely ordered tests would not have been performed if testing had only been done for recognizable indications; only 0.22 percent of these revealed abnormalities that might influence perioperative management [",
"      <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/3\">",
"       3",
"      </a>",
"      ]. Further chart review determined that these abnormalities were not acted upon, nor did they have adverse surgical consequences.",
"     </li>",
"     <li>",
"      One report found that only ten routine laboratory test results in 3782 patients required treatment; just one of these required pharmacologic treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/4\">",
"       4",
"      </a>",
"      ]. In a prospective study of 1363 patients for whom laboratory testing was performed at the discretion of the perioperative physician, only an abnormal ECG predicted postoperative complications. Abnormalities in commonly performed blood test and chest radiography had no predictive value [",
"      <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Investigators performed a retrospective review of 73,596 patients undergoing elective hernia repair using the National Surgical Quality Improvement Program (NSQIP) database [",
"      <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/6\">",
"       6",
"      </a>",
"      ]. Preoperative tests were performed in 63.8 percent of patients; 61.6 percent of these patients had at least one abnormal test result. Among patients with no accepted medical indication for testing, 54 percent nonetheless received at least one test. After adjustment for demographics, comorbidities, and procedure characteristics, neither preoperative testing nor the finding of an abnormal test result were associated with adverse postoperative outcomes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Predictive value",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several arguments for avoiding routine preoperative tests. Normal test values are usually arbitrarily defined as those occurring within two standard deviations from the mean, thereby ensuring that 5 percent of healthy individuals who have a single screening test will have an abnormal result. As more tests are ordered, the likelihood of a false positive test increases; a screening panel containing 20 independent tests in a patient with no disease will yield at least one abnormal result 64 percent of the time (",
"    <a class=\"graphic graphic_table graphicRef60009 \" href=\"UTD.htm?3/52/3915\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Thus, the predictive value of abnormal test results is low in healthy patients with a low prevalence of disease (",
"    <a class=\"graphic graphic_table graphicRef55083 \" href=\"UTD.htm?0/53/859\">",
"     table 2",
"    </a>",
"    ). Aside from possibly causing patient alarm, the additional testing prompted by false positive screening tests leads to unnecessary costs, risks, and a potential delay of surgery. In addition, clinicians often fail to act upon abnormal test results from routine preoperative testing, thereby creating an additional medicolegal risk.",
"   </p>",
"   <p>",
"    A review of studies of routine preoperative testing pooled data and estimated the incidence of abnormalities that affect patient management and the positive and negative likelihood ratios for a postoperative complication (",
"    <a class=\"graphic graphic_table graphicRef75939 \" href=\"UTD.htm?27/45/28380\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/7\">",
"     7",
"    </a>",
"    ]. For nearly all potential laboratory studies, a normal test did not substantially reduce the likelihood of a postoperative complication (the negative likelihood ratio approached 1.0). Positive likelihood ratios were modest, and they exceeded 3.0 for only three tests (hemoglobin, renal function, and electrolytes); however, clinical evaluation can predict most patients with an abnormal result. This was illustrated by the low incidence of a change in preoperative management based on an abnormal test result (0 to 3 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, the overall risk of surgery is extremely low in healthy individuals. Therefore, the ability to stratify risk by commonly performed evaluations is limited.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Screening questionnaire",
"    </span>",
"    &nbsp;&mdash;&nbsp;Screening questions appear on many standard institutional preoperative evaluation forms. One validated screening instrument, derived from 100 patients, comprises 17 questions that allowed nurses to identify those patients who would benefit from a formal preoperative evaluation by an anesthesiologist (",
"    <a class=\"graphic graphic_table graphicRef66690 \" href=\"UTD.htm?37/36/38475\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/8\">",
"     8",
"    </a>",
"    ]. The questions chosen for this questionnaire were devised to detect pre-existing conditions shown to be associated with perioperative adverse events.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Age",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of commonly employed and validated indices consider age as a minor component of preoperative coronary risk. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=see_link\">",
"     \"Estimation of cardiac risk prior to noncardiac surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some studies found a small increased risk of surgery associated with advancing age [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. In a review of 50,000 elderly patients, for example, the risk of mortality with elective surgery increased from 1.3 percent for those under 60 years of age, to 11.3 percent in the 80 to 89 year-old age group [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/10\">",
"     10",
"    </a>",
"    ]. Among 1.2 million Medicare patients undergoing elective surgery, mortality risk increased linearly with age for most surgical procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/11\">",
"     11",
"    </a>",
"    ]. Operative mortality for patients 80 years and older was more than twice that of patients 65 to 69 years old. However, age was not a significant predictor of cardiac complications after multivariable analysis in the cohort of patients used to derive a revised cardiac risk index [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to the minor influence of age on perioperative cardiac risk, there is more robust literature supporting age as an independent risk factor for postoperative pulmonary complications. Age was one of the most important patient-related predictors of pulmonary risk, even after adjusting for common age-related comorbidities, in a systematic review [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/8/1162?source=see_link\">",
"     \"Evaluation of preoperative pulmonary risk\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast, some studies have found little relation between age and mortality rates due to surgery. One study reported the outcomes of surgery in 795 patients over 90 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/14\">",
"     14",
"    </a>",
"    ]. No patients were Class I as classified by the American Society of Anesthesiologists (ASA) classification (",
"    <a class=\"graphic graphic_table graphicRef56098 \" href=\"UTD.htm?8/33/8733\">",
"     table 5",
"    </a>",
"    ); 80 percent were ASA Class III or greater. Despite higher perioperative mortality rates in the elderly, survival at two years was no different than the actuarial survival in matched patients not undergoing surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/14\">",
"     14",
"    </a>",
"    ]. A larger study of 4315 patients also found a higher perioperative complication and mortality rate in older individuals, but the mortality rate was low [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/15\">",
"     15",
"    </a>",
"    ]. Among 31 patients age 100 years and older undergoing surgery requiring anesthesia, perioperative and one-year mortality rates were similar to matched peers from the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Much of the risk associated with age is due to increasing numbers of comorbidities that confer excess risk. After adjusting for comorbidities more common with age, the impact of age on perioperative outcomes is modest. Thus, age should not be used as the sole criterion to guide preoperative testing or to withhold a surgical procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Exercise capacity",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients should be asked about their exercise capacity as part of the preoperative evaluation. Exercise capacity is an important determinant of overall perioperative risk; patients with virtually unlimited exercise tolerance generally have low risk.",
"   </p>",
"   <p>",
"    The ability to walk two blocks on level ground or carry two bags of groceries up one flight of stairs without symptoms are simple questions that can give a rough assessment of patient risk [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/18\">",
"     18",
"    </a>",
"    ]. These activities expend approximately 4 metabolic energy equivalents (METs) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=see_link&amp;anchor=H4#H4\">",
"     \"Estimation of cardiac risk prior to noncardiac surgery\", section on 'Functional capacity'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In general, healthy patients who can perform these activities as part of their daily routine have a low risk for major postoperative complications. This was illustrated in a study of 600 consecutive patients undergoing major surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/20\">",
"     20",
"    </a>",
"    ]. Investigators asked each patient to estimate the number of blocks that they could walk on level ground and the number of flights of stairs they could climb without symptoms. The authors defined poor exercise capacity as the inability to either walk four blocks or climb two flights of stairs. Patients reporting poor exercise capacity had twice as many serious postoperative complications as those who reported good exercise capacity (20 versus 10 percent, respectively). There was also a significant difference in cardiovascular complications (10 versus 5 percent), but not for total pulmonary complications (9 versus 6 percent).",
"   </p>",
"   <p>",
"    The importance of functional capacity was confirmed objectively in another report of 847 patients undergoing elective abdominal surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/21\">",
"     21",
"    </a>",
"    ]. In this study, poor exercise capacity, confirmed by cardiopulmonary exercise testing, was a stronger predictor of all-cause mortality than any of the conventional cardiac risk factors of the Revised Cardiac Risk Index.",
"   </p>",
"   <p>",
"    The American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart Association guideline on preoperative cardiac evaluation recommends no testing for patients with good exercise capacity (at least four METs) regardless of the intrinsic risk of the planned procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Medication use",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians should obtain a history of medication use for all patients before surgery and should specifically inquire about over-the-counter, complementary, and alternative medications.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     Aspirin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/38/15978?source=see_link\">",
"     ibuprofen",
"    </a>",
"    , and other nonsteroidal anti-inflammatory drugs are readily available and are associated with an increased risk of perioperative bleeding. Specific inquiry about use of complementary and alternative medications should also be part of the preoperative assessment. A detailed discussion of perioperative medication management is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/45/40666?source=see_link\">",
"     \"Perioperative medication management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Obesity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contrary to popular belief, in noncardiac surgery, obesity is not a risk factor for most major adverse postoperative outcomes, with the exception of pulmonary embolism. None of the published and widely disseminated cardiac risk indices for non-cardiac surgery include obesity as a risk factor for postoperative cardiac complications.",
"   </p>",
"   <p>",
"    However, in cardiac surgery, some studies have shown higher complication rates for obese patients, including increased hospital stay [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/22\">",
"     22",
"    </a>",
"    ], wound infections [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/22,23\">",
"     22,23",
"    </a>",
"    ], prolonged mechanical ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/23\">",
"     23",
"    </a>",
"    ], and atrial arrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Representative studies related to postoperative mortality in noncardiac surgery include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a matched case control study of 1962 patients undergoing noncardiac surgery, obesity was not associated with increased mortality (1.1 percent in obese patients versus 1.2 percent in controls) [",
"      <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a large, multi-institutional, prospective cohort of 118,707 patients undergoing nonbariatric general surgery, obesity was inversely associated with postoperative mortality (OR 0.85, 95% CI 0.75-0.99), a phenomenon termed the 'obesity paradox' [",
"      <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/26\">",
"       26",
"      </a>",
"      ]. The authors suggest that the obese state carries a low-grade, chronic inflammatory that may be 'primed' to mount an appropriate inflammatory and immune response to the stress of surgery, in addition to supplying more nutritional reserve.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other studies relating to complications in noncardiac surgery found that obesity increases rates for wound infections, but has no effect on other postoperative complications [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/27-31\">",
"     27-31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Obesity is also not a risk factor for postoperative pulmonary conditions other than pulmonary embolism. In a review which found that the unadjusted relative risks for pulmonary complications due to obesity were 0.8 to 1.7, the incidence of pulmonary complications was 21 percent in both obese and non-obese patients [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/31\">",
"     31",
"    </a>",
"    ]. In another systematic review, only one of eight eligible studies using multivariable analysis to adjust for confounders found that obesity was a predictor of postoperative pulmonary risk [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The one exception to the observation that obesity does not increase the risk of noncardiac surgery is venous thromboembolism. Obesity is a major risk factor for postoperative deep venous thrombosis and pulmonary embolism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/52/41802?source=see_link\">",
"     \"Prevention of venous thromboembolic disease in surgical patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6631824\">",
"    <span class=\"h2\">",
"     Obstructive sleep apnea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obstructive sleep apnea (OSA) increases the risk for postoperative medical complications including hypoxemia, respiratory failure, unplanned reintubation, and ICU transfer [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/32\">",
"     32",
"    </a>",
"    ]. Most patients with obstructive sleep apnea are undiagnosed. The prevalence of previously undetected obstructive sleep apnea is particularly high in patients preparing for bariatric surgery. Given the increased risks of perioperative morbidity and the potential for altered anesthetic management, it is reasonable to screen patients for OSA before surgery with one of several validated screening instruments. A detailed discussion of the perioperative risks and the role of screening for OSA is presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35288?source=see_link\">",
"     \"Surgical risk and the preoperative evaluation and management of adults with obstructive sleep apnea\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7355406\">",
"    <span class=\"h2\">",
"     Alcohol misuse",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who misuse alcohol on a regular basis have an increased risk for postoperative complications [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/33\">",
"     33",
"    </a>",
"    ].",
"    <strong>",
"    </strong>",
"   </p>",
"   <p>",
"    In a study of 9176 male US veterans, a screening questionnaire for alcohol misuse administered at any time within one year before surgery accurately stratified risk of postoperative complications [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/34\">",
"     34",
"    </a>",
"    ]. There was a continuous relationship between postoperative complications and risk scores using the Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) questionnaire (",
"    <a class=\"graphic graphic_table graphicRef53246 \" href=\"UTD.htm?13/42/13996\">",
"     table 6",
"    </a>",
"    ). Surgical site infections, other infections, and cardiopulmonary complications each increased across the strata of risk groups based on alcohol use patterns. A similarly conducted trial of the AUDIT-C questionnaire before total joint arthroplasty revealed comparable results [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/35\">",
"     35",
"    </a>",
"    ]. Patients with high AUDIT-C scores (9 to 12 of 12 possible points) within the year before surgery also have longer lengths of stay, more ICU days, and higher unplanned reoperation rates [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most trials of alcohol cessation interventions have been conducted in the nonoperative setting; a small study in patients undergoing colorectal surgery reported a beneficial effect of alcohol screening on postoperative complications [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/37\">",
"     37",
"    </a>",
"    ]. The optimal period of cessation is unknown but at least four weeks of abstinence are required to reverse selected physiologic abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Screening for alcohol misuse before surgery will identify a subset of patients at increased risk for postoperative medical complications. While the benefit of directed alcohol cessation programs before surgery is not well established in the literature, there is little apparent risk to such a strategy. The preoperative period also serves as an opportunity to identify patients who misuse alcohol and are candidates for intervention as part of primary care follow-up after surgery. Pending further study, it is reasonable to screen all patients for alcohol misuse before elective major surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33505198\">",
"    <span class=\"h2\">",
"     Smoking",
"    </span>",
"    &nbsp;&mdash;&nbsp;Current smoking is associated with postoperative morbidity and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/38\">",
"     38",
"    </a>",
"    ]. Smoking cessation prior to surgery may prevent postoperative complications.",
"   </p>",
"   <p>",
"    A meta-analysis of six randomized trials found that stopping smoking prior to surgery led to a lower risk of total postoperative complications (RR 0.59, 95% CI 0.41-0.85) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/39\">",
"     39",
"    </a>",
"    ]. The same meta-analysis also pooled data from 15 observational studies and found that smoking cessation led to decreased wound healing complications (RR 0.73, CI 0.61-0.87) and pulmonary complications (RR 0.81, CI 0.70-0.93). Longer periods of smoking cessation prior to surgery were associated with lower rates of postoperative complications. A separate contemporaneous systematic review found similar results [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Evaluating for tobacco use and offering strategies to quit smoking may reduce risk of postoperative wound and pulmonary complications. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/3/23609?source=see_link\">",
"     \"Overview of smoking cessation management in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12904?source=see_link\">",
"     \"Smoking cessation counseling strategies in primary care\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6635260\">",
"    <span class=\"h2\">",
"     Personal or family history of anesthetic complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignant hyperthermia is a rare complication of anesthetic administration that is inherited in an autosomal dominant fashion. Due to the morbidity and potential mortality associated with this condition, the preoperative history should include questioning about either a personal or family history of complications from anesthesia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/3/36921?source=see_link\">",
"     \"Susceptibility to malignant hyperthermia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32984?source=see_link\">",
"     \"Malignant hyperthermia: Clinical diagnosis and management of acute crisis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     LABORATORY EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several review articles in perioperative consultation and most local institutional policies support a selective approach to preoperative testing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/3,7,18,41-44\">",
"     3,7,18,41-44",
"    </a>",
"    ]. A practice advisory from the American Society of Anesthesiologists and a safety guideline from the Association of Anaesthetists of Great Britain and Ireland recommend against routine preoperative laboratory testing in the absence of clinical indications [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/44,45\">",
"     44,45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Timing of laboratory testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;When laboratory tests are felt to be necessary, it is probably safe to use test results that were performed and were normal within the past four months, unless there has been an interim change in clinical status. The validity of this approach was illustrated in an observational study which investigated the usefulness of 7549 preoperative tests performed in 1109 patients undergoing elective surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/41\">",
"     41",
"    </a>",
"    ]. The tests were duplicates of those performed within the year prior to surgery in 47 percent of cases:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Of 3096 previous results that were normal (as defined by hospital reference range) and performed closest to the time of but before admission (median interval two months), only 13 (0.4 percent) values were outside a range considered acceptable for surgery. Most of these abnormalities were predictable from the patient's history, and most were not noted in the medical record.",
"     </li>",
"     <li>",
"      In contrast, of 461 previous tests that were abnormal, 78 (17 percent) repeat values at admission were outside a range considered acceptable for surgery, suggesting that tests that have recently been abnormal should be repeated preoperatively.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Laboratory studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;While preoperative laboratory testing is not routinely indicated, selective testing is appropriate in specific circumstances, including patients with known underlying diseases or risk factors that would affect operative management or increase risk, and specific high risk surgical procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/42\">",
"     42",
"    </a>",
"    ]. Specific laboratory studies commonly ordered for preoperative evaluation include a complete blood count, electrolytes, renal function, blood glucose, liver function studies, hemostasis evaluation, and urinalysis. These tests are discussed below with indications for their use in specific populations and surgeries.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Complete blood count",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anemia is present in approximately 1 percent of asymptomatic patients; surgically significant anemia has an even lower prevalence [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/3\">",
"     3",
"    </a>",
"    ]. However, anemia is common following major surgery and the preoperative hemoglobin level predicts postoperative mortality. As an example, a large observational study of older veterans (n = 310,311, age &ge;65 years) found an increase in 30-day postoperative mortality for patients with mildly abnormal preoperative hematocrits undergoing major noncardiac surgery, even in the absence of significant blood loss [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/46\">",
"     46",
"    </a>",
"    ]. Adjusted mortality increased by 1.6 percent (95% CI 1.1 to 2.2 percent) for every one percentage point increase or decrease from a normal hematocrit, defined as 39.0 to 53.9 percent.",
"   </p>",
"   <p>",
"    The data cannot distinguish whether an abnormal hematocrit serves as a marker for coexistent disease that increases mortality risk, or whether the anemia itself increases physiologic stresses and therefore complication rates. &nbsp;",
"   </p>",
"   <p>",
"    The observation that outcomes do not differ for patients undergoing hip surgery who were randomly assigned to either liberal or restrictive transfusion policies suggests that anemia is a marker for risk, rather than the cause of morbidity [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/47\">",
"     47",
"    </a>",
"    ]. It remains unclear if the increased risk due to anemia is modifiable by interventions aimed at correcting the hematocrit.",
"   </p>",
"   <p>",
"    A baseline hemoglobin measurement is suggested for all patients 65 years of age or older who are undergoing major surgery, and for younger patients undergoing major surgery that is expected to result in significant blood loss. In contrast, hemoglobin measurement is not necessary for those undergoing minor surgery unless the history suggests anemia.",
"   </p>",
"   <p>",
"    The frequency of significant unsuspected white blood cell or platelet abnormalities is low [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/3\">",
"     3",
"    </a>",
"    ]. Unlike the hemoglobin concentration, however, there is little rationale to support baseline testing of either. Nevertheless, obtaining a complete blood count, including white count and platelet measurement, can be recommended if the cost is not substantially greater than the cost of a hemoglobin concentration alone. There may be some costs incurred due to follow-up of false positive results; however, with respect to platelet counts, these costs do not appear to be substantial [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Renal function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mild to moderate renal impairment is usually asymptomatic; the prevalence of an elevated creatinine among asymptomatic patients with no history of renal disease is only 0.2 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/3,49\">",
"     3,49",
"    </a>",
"    ]. However, the prevalence increases with age. In one study, for example, the prevalence among unselected patients aged 46 to 60 was 9.8 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the revised cardiac risk index, a serum creatinine &gt;2.0",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (177",
"    <span class=\"nowrap\">",
"     &micro;mol/L)",
"    </span>",
"    was one of six independent factors that predicted postoperative cardiac complications [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/12\">",
"     12",
"    </a>",
"    ]. Renal insufficiency is also an independent risk factor for postoperative pulmonary complications [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/13\">",
"     13",
"    </a>",
"    ] and a major predictor of postoperative mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/51\">",
"     51",
"    </a>",
"    ]. Renal insufficiency necessitates dosage adjustment of some medications that may be used perioperatively (eg, muscle relaxants).",
"   </p>",
"   <p>",
"    For these reasons, it is appropriate to obtain a serum creatinine concentration in patients over the age of 50 undergoing intermediate or high risk surgery, although there is no clear consensus on this point. &nbsp;It should also be ordered when hypotension is likely, or when nephrotoxic medications will be used.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Electrolytes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency of unexpected electrolyte abnormalities is low (0.6 percent in one report) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/3\">",
"     3",
"    </a>",
"    ]. In addition, the relationship between most of these derangements and operative morbidity is not clear. Furthermore, clinicians can predict most abnormalities based on history (for example, current use of a diuretic, angiotensin converting enzyme (ACE) inhibitor, or angiotensin receptor blocker (ARB), or known chronic kidney disease).",
"   </p>",
"   <p>",
"    Thus, routine electrolyte determinations are NOT recommended unless the patient has a history that increases the likelihood of an abnormality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Blood glucose",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency of glucose abnormalities increases with age; almost 25 percent of patients over age 60 had an abnormal value in one report [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/50\">",
"     50",
"    </a>",
"    ]. Most controlled studies have not found a relationship between operative risk and diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/9,50\">",
"     9,50",
"    </a>",
"    ], except in patients undergoing vascular surgery or coronary artery bypass grafting [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. While the revised cardiac risk index identified diabetes as a risk factor for postoperative cardiac complications, only patients with insulin-treated diabetes were at risk [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/12\">",
"     12",
"    </a>",
"    ]. There is no evidence that asymptomatic hyperglycemia, in a patient not previously known to have diabetes, increases surgical risk. The rate of asymptomatic hyperglycemia in unselected surgical patients is low; in one report the incidence was only 1.2 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Unexpected abnormal blood glucose results do not often influence perioperative management. As an example, one study evaluated the benefit of routine laboratory testing in 1010 presumably healthy patients undergoing cholecystectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/49\">",
"     49",
"    </a>",
"    ]. Eight patients had unexpected elevations in preoperative serum glucose; only one of these patients developed significant postoperative hyperglycemia and this was not recognized until after",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/40/42628?source=see_link\">",
"     total parenteral nutrition",
"    </a>",
"    was started. No patient in this study benefited from routine preoperative measurement of serum glucose.",
"   </p>",
"   <p>",
"    Thus, routine measurement of blood glucose is NOT recommended for preoperative healthy patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Liver function tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unexpected liver enzyme abnormalities are uncommon, occurring in only 0.3 percent of patients in one series [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/4\">",
"     4",
"    </a>",
"    ]. In a pooled data analysis, only 0.1 percent of all routine preoperative liver function tests changed preoperative management (",
"    <a class=\"graphic graphic_table graphicRef75939 \" href=\"UTD.htm?27/45/28380\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/7\">",
"     7",
"    </a>",
"    ]. In a study of the National Surgical Quality Improvement Program database, among 25,149 patient with no comorbidities, the relative risk for major postoperative complications among patients who received preoperative liver function tests, when compared to those with no testing, approached one (RR 0.94, 95% CI 0.42-2.08) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Severe liver function test abnormalities among patients with cirrhosis or acute liver disease are associated with increased surgical morbidity and mortality, but no data suggest that mild abnormalities among patients with no known liver disease have a similar impact [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/55\">",
"     55",
"    </a>",
"    ]. Clinically-significant liver disease would most likely be suspected on the basis of the history and physical examination; thus, routine liver enzyme testing is NOT recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Tests of hemostasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unexpected significant abnormalities of the prothrombin time (PT) or partial thromboplastin time (PTT) are uncommon [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/3,48\">",
"     3,48",
"    </a>",
"    ]. Inherited coagulation defects are quite rare. For example, the incidence of hemophilia A and B among men is 1:5000 and 1:30000 respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/56\">",
"     56",
"    </a>",
"    ]. Nearly all of these cases would be evident based on clinical presentation prior to the preoperative medical evaluation. In addition, the relationship between an abnormal result and the risk of perioperative hemorrhage is not well defined, but appears to be quite low, particularly in those who are thought to have a low risk of hemorrhage on the basis of history and physical examination [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. Even among neurosurgical patients, for whom a small amount of unanticipated bleeding could cause substantial morbidity, the medical history is the most useful screening test for bleeding diathesis. In a study of 11,804 patients undergoing spinal or intracranial surgery, a medical history that suggested risk for bleeding complications was substantially more sensitive that PT or PTT values in predicting need for transfusion, unplanned reoperation, and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a pooled data analysis, an abnormal PT had a positive likelihood ratio of 0 for predicting a postoperative complication, and a negative likelihood ratio of 1.01 (",
"    <a class=\"graphic graphic_table graphicRef75939 \" href=\"UTD.htm?27/45/28380\">",
"     table 3",
"    </a>",
"    ); in no case did the finding of an abnormal PT change patient management or modify the likelihood of a complication [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/7\">",
"     7",
"    </a>",
"    ]. Similarly, the bleeding time is not useful in assessing the risk of perioperative hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/60,61\">",
"     60,61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, routine preoperative tests of hemostasis are NOT recommended. We advise testing in patients with a known personal or family history of bleeding diathesis, or an illness associated with bleeding tendency [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The role of preoperative hemostasis evaluation in patients undergoing intermediate- to high-risk surgical procedures is somewhat controversial. We suggest NOT performing PT and PTT in such patients. This is consistent with the position of the British Committee for Standards in Haematology [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/62\">",
"     62",
"    </a>",
"    ] and the American Society of Anesthesiologists [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/63\">",
"     63",
"    </a>",
"    ]. Others, including authors for UpToDate, have suggested testing all patients undergoing intermediate to high risk surgical procedures, as clinicians may forget to ask about bleeding, or patient history may be unreliable. As discussed above, there is no evidence to support this practice. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/43/32439?source=see_link\">",
"     \"Preoperative assessment of hemostasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Urinalysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The theoretical reason to obtain a preoperative urinalysis is detection of unsuspected renal disease",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    urinary tract infection. Asymptomatic renal disease can be detected by measurement of serum creatinine in selected patients. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Renal function'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Urinary tract infections have the potential to cause bacteremia and post-surgical wound infections, particularly with prosthetic surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/64\">",
"     64",
"    </a>",
"    ]. Patients with positive urinalysis and urine culture are generally treated with antibiotics and proceed with surgery without delay [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/65\">",
"     65",
"    </a>",
"    ]. However, it is unclear whether a positive preoperative urinalysis and culture with subsequent antibiotic treatment prevent post-surgical infection. One study found no difference in wound infection between patients with normal and abnormal urinalysis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/66\">",
"     66",
"    </a>",
"    ]. Another study found that patients with asymptomatic urinary tract infection detected by urinalysis had an increased risk of wound infection post-operatively, despite treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A cost-effectiveness analysis estimated that 4.58 wound infections in nonprosthetic knee operations may be prevented annually by the use of routine urinalysis, at a cost of $1,500,000 per wound infection prevented [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, routine urinalysis is NOT recommended preoperatively for most surgical procedures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2750321\">",
"    <span class=\"h3\">",
"     Pregnancy testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The knowledge that a woman is pregnant substantially changes perioperative management. The patient may elect to cancel elective surgery, or may decide in collaboration with her physicians to undertake a different, lower risk surgery than originally planned. In addition, anesthetic technique differs for pregnant women, and there may be risks to the fetus if a pregnancy goes undetected before surgery and anesthesia.",
"   </p>",
"   <p>",
"    The National Patient Safety Agency in the United Kingdom recommends to always check whether a woman may be pregnant before surgery, and if pregnancy is possible after history taking, to offer a pregnancy test [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/69\">",
"     69",
"    </a>",
"    ]. The American Society of Anesthesiologists recommends that clinicians offer pregnancy testing for women of childbearing age if the results would alter management [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/44\">",
"     44",
"    </a>",
"    ]. While these guidelines provide some discretion in deciding which women to test, it is often not possible to reliably exclude pregnancy based on medical history taking alone [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/70\">",
"     70",
"    </a>",
"    ]. Many institutions require pregnancy testing for all reproductive age women before surgery. There is low risk to this approach; false positives are rare, testing is inexpensive, and the results return rapidly. Thus, we suggest pregnancy testing in all reproductive age women prior to surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44808?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical manifestations and diagnosis of early pregnancy\", section on 'Detection of hCG'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     ELECTROCARDIOGRAM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electrocardiograms (ECGs) have a low likelihood of changing perioperative management in the absence of known cardiac disease. Nevertheless, detecting a recent myocardial infarction is important since it is associated with high surgical morbidity and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=see_link\">",
"     \"Estimation of cardiac risk prior to noncardiac surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The prevalence of abnormal ECGs increases with age [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/71\">",
"     71",
"    </a>",
"    ]. Important ECG abnormalities in patients younger than 45 years with no known cardiac disease are very infrequent. &nbsp;",
"   </p>",
"   <p>",
"    The electrocardiogram alone may be a poor overall predictor of postoperative cardiac complications [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/72\">",
"     72",
"    </a>",
"    ]. On the other hand, a preoperative ECG can be important as a baseline to compare with postoperative ECG abnormalities.",
"   </p>",
"   <p>",
"    The 2007 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart Association",
"    <span class=\"nowrap\">",
"     (ACC/AHA)",
"    </span>",
"    Guidelines on Perioperative Cardiovascular Evaluation state that ECG is not useful in asymptomatic patients undergoing low risk procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/18\">",
"     18",
"    </a>",
"    ]. Similarly, the European Society of Cardiology 2009 preoperative guidelines do not recommend ECG in patients without risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The 2007",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines do recommend a preoperative resting 12-lead ECG for selected patients as follows (",
"    <a class=\"graphic graphic_table graphicRef53530 \" href=\"UTD.htm?19/6/19564\">",
"     table 7",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with at least one clinical risk factor scheduled to undergo vascular surgery. These clinical risk factors are ischemic heart disease, compensated or prior heart failure, cerebrovascular disease, diabetes, and renal insufficiency.",
"     </li>",
"     <li>",
"      Patients scheduled to undergo intermediate-risk surgery with known cardiovascular disease, peripheral artery disease, or cerebrovascular disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    gave a less strong recommendation to perform an ECG for patients scheduled to undergo vascular surgery with no clinical risk factors (class IIa) OR those scheduled to undergo intermediate-risk surgery with at least one clinical risk factor (class IIb).",
"   </p>",
"   <p>",
"    It is uncertain whether the preoperative approach to obese patients should differ from that of the general population in regard to ECGs. The AHA 2009 scientific advisory on cardiovascular evaluation and management of severely obese patients (BMI &ge;40",
"    <span class=\"nowrap\">",
"     kg/m2)",
"    </span>",
"    undergoing surgery states that an ECG is reasonable in all obese patients with at least one risk factor for coronary heart disease (diabetes, smoking, hypertension, or hyperlipidemia) or poor exercise tolerance [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     CHEST RADIOGRAPH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preoperative chest x-rays add little to the clinical evaluation in identifying patients at risk for perioperative complications [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/43\">",
"     43",
"    </a>",
"    ]. Abnormal findings on chest x-ray occur frequently, and are more prevalent in older patients. Several systematic reviews and independent advisory organizations in the US and Europe recommend against routine chest radiograph in healthy patients [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/75-78\">",
"     75-78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is little evidence to support the use of a preoperative chest radiograph regardless of age unless there is known or suspected cardiopulmonary disease from the history or physical examination. In a meta-analysis of 21 studies of routine chest radiography, among a total of 14,390 routine chest x-rays, there were 1444 abnormal studies [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/79\">",
"     79",
"    </a>",
"    ]. Only 140 abnormal findings were unexpected, and only 14 (0.1 percent) of all routine chest x-rays influenced management.",
"   </p>",
"   <p>",
"    One study screened 905 surgical admissions for the presence of clinical factors that were thought to be risk factors for an abnormal preoperative chest x-ray [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/80\">",
"     80",
"    </a>",
"    ]. The risk factors included age over 60 years, or clinical findings consistent with cardiac or pulmonary disease. No risk factors were evident in 368 patients; of these, only one (0.3 percent) had an abnormal chest x-ray, which did not affect the surgery. On the other hand, 504 patients had identifiable risk factors; of these, 114 (22 percent) had significant abnormalities on preoperative chest x-ray.",
"   </p>",
"   <p>",
"    While routine preoperative chest x-rays are not indicated, we agree with the American College of Physicians (ACP) recommendation for chest x-rays in patients with cardiopulmonary disease and those older than 50 years of age who are undergoing abdominal aortic aneurysm surgery or upper",
"    <span class=\"nowrap\">",
"     abdominal/thoracic",
"    </span>",
"    surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/13\">",
"     13",
"    </a>",
"    ]. Posteroanterior and lateral chest x-ray is also suggested by the American Heart Association for patients with severe obesity (BMI &ge;40",
"    <span class=\"nowrap\">",
"     kg/m2)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/74\">",
"     74",
"    </a>",
"    ]. In these patients, the chest radiograph may indicate undiagnosed heart failure, cardiac chamber enlargement, or abnormal pulmonary vascularity suggestive of pulmonary hypertension, warranting further cardiovascular investigation. The relationship between findings on chest x-ray and perioperative morbidity are not well defined in these populations, however, and studies are not available that indicate that preoperative radiography changes perioperative outcomes. Thus, we do not suggest routine chest x-rays in severely obese patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     PULMONARY FUNCTION TESTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine pulmonary function tests are NOT indicated for healthy patients prior to surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/8/1162?source=see_link\">",
"     \"Evaluation of preoperative pulmonary risk\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These tests generally should be reserved for patients who have dyspnea that remains unexplained after careful clinical evaluation. Clinical findings are more predictive of the risk of postoperative pulmonary complication than are spirometric results [",
"    <a class=\"abstract\" href=\"UTD.htm?10/4/10314/abstract/81\">",
"     81",
"    </a>",
"    ]. These findings include decreased breath sounds, prolonged expiratory phase, rales, rhonchi, or wheezes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?29/52/30530?source=see_link\">",
"       \"Patient information: Questions to ask if you are having a procedure or surgery (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The overall risk of surgery is low in healthy individuals. Preoperative tests usually lead to false-positive results, unnecessary costs, and a potential delay of surgery. Preoperative tests should not be performed unless there is a clear clinical indication.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A simple screening questionnaire can be helpful in the preoperative evaluation (",
"      <a class=\"graphic graphic_table graphicRef66690 \" href=\"UTD.htm?37/36/38475\">",
"       table 4",
"      </a>",
"      ). Important potential risk factors to discuss with the patient include age, exercise capacity, alcohol, smoking, and medication use. Obesity is not a risk factor for most major adverse postoperative outcomes in patients undergoing noncardiac surgery. Clinicians should also inquire about personal or family history of complications from anesthesia and screen for symptoms of obstructive sleep apnea. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Routine preoperative laboratory tests have not been shown to improve patient outcomes among healthy patients undergoing surgery. In addition, routine testing in healthy patients has poor predictive value, leading to false-positive test results",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      increased medicolegal risk for not following up on abnormal test results. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Rationale for selective testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest baseline hemoglobin measurement for all patients 65 years of age or older who are undergoing major surgery and for younger patients undergoing surgery that is expected to result in significant blood loss (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). For other healthy patients, we suggest NOT performing routine hemoglobin, white blood count, or platelet measurements (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Complete blood count'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the revised cardiac risk index, a serum creatinine &gt;2.0",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (177",
"      <span class=\"nowrap\">",
"       micromol/L)",
"      </span>",
"      predicted postoperative cardiac complications. We suggest NOT obtaining a serum creatinine concentration, except in the following patients (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      )&nbsp;(see",
"      <a class=\"local\" href=\"#H14\">",
"       'Renal function'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Patients over the age of 50 undergoing intermediate or high risk surgery.",
"     </li>",
"     <li>",
"      Younger patients suspected of having renal disease, when hypotension is likely during surgery, or when nephrotoxic medications will be used.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest NOT testing for serum electrolytes, blood glucose, liver function, hemostasis, or urinalysis in the healthy preoperative patient (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). We suggest pregnancy testing in all reproductive age women prior to surgery, rather than use of history-taking alone to determine pregnancy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Laboratory studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest NOT ordering an ECG for asymptomatic patients undergoing low risk surgical procedures (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). In accord with the 2007 American College of",
"      <span class=\"nowrap\">",
"       Cardiology/American",
"      </span>",
"      Heart Association",
"      <span class=\"nowrap\">",
"       (ACC/AHA)",
"      </span>",
"      guidelines, we suggest a 12-lead ECG in patients without perioperative clinical risk factor who require vascular surgical procedures (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). In addition, a 12-lead ECG is part of the evaluation in patients with preexisting cardiovascular disease who are undergoing intermediate-risk surgery and in severely obese patients with poor effort tolerance or at least one additional cardiovascular risk factor. This is discussed in detail elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=see_link&amp;anchor=H6#H6\">",
"       \"Estimation of cardiac risk prior to noncardiac surgery\", section on 'Resting electrocardiogram'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H20\">",
"       'Electrocardiogram'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that clinicians NOT order routine preoperative chest x-rays or pulmonary function tests in the healthy patient (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). We suggest obtaining a preoperative chest x-ray in patients with cardiopulmonary disease and those older than 50 years of age who are undergoing abdominal aortic aneurysm surgery or upper",
"      <span class=\"nowrap\">",
"       abdominal/thoracic",
"      </span>",
"      surgery (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Chest radiograph'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H22\">",
"       'Pulmonary function tests'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/1\">",
"      Chung F, Yuan H, Yin L, et al. Elimination of preoperative testing in ambulatory surgery. Anesth Analg 2009; 108:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/2\">",
"      Keay L, Lindsley K, Tielsch J, et al. Routine preoperative medical testing for cataract surgery. Cochrane Database Syst Rev 2012; 3:CD007293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/3\">",
"      Kaplan EB, Sheiner LB, Boeckmann AJ, et al. The usefulness of preoperative laboratory screening. JAMA 1985; 253:3576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/4\">",
"      Narr BJ, Hansen TR, Warner MA. Preoperative laboratory screening in healthy Mayo patients: cost-effective elimination of tests and unchanged outcomes. Mayo Clin Proc 1991; 66:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/5\">",
"      Fritsch G, Flamm M, Hepner DL, et al. Abnormal pre-operative tests, pathologic findings of medical history, and their predictive value for perioperative complications. Acta Anaesthesiol Scand 2012; 56:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/6\">",
"      Benarroch-Gampel J, Sheffield KM, Duncan CB, et al. Preoperative laboratory testing in patients undergoing elective, low-risk ambulatory surgery. Ann Surg 2012; 256:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/7\">",
"      Smetana GW, Macpherson DS. The case against routine preoperative laboratory testing. Med Clin North Am 2003; 87:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/8\">",
"      Hilditch WG, Asbury AJ, Jack E, McGrane S. Validation of a pre-anaesthetic screening questionnaire. Anaesthesia 2003; 58:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/9\">",
"      Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977; 297:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/10\">",
"      Linn BS, Linn MW, Wallen N. Evaluation of results of surgical procedures in the elderly. Ann Surg 1982; 195:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/11\">",
"      Finlayson EV, Birkmeyer JD. Operative mortality with elective surgery in older adults. Eff Clin Pract 2001; 4:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/12\">",
"      Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/13\">",
"      Smetana GW, Lawrence VA, Cornell JE, American College of Physicians. Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med 2006; 144:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/14\">",
"      Hosking MP, Warner MA, Lobdell CM, et al. Outcomes of surgery in patients 90 years of age and older. JAMA 1989; 261:1909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/15\">",
"      Polanczyk CA, Marcantonio E, Goldman L, et al. Impact of age on perioperative complications and length of stay in patients undergoing noncardiac surgery. Ann Intern Med 2001; 134:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/16\">",
"      Warner MA, Saletel RA, Schroeder DR, et al. Outcomes of anesthesia and surgery in people 100 years of age and older. J Am Geriatr Soc 1998; 46:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/17\">",
"      Lubin MF. Is age a risk factor for surgery? Med Clin North Am 1993; 77:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/18\">",
"      Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 2009; 120:e169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/19\">",
"      Hlatky MA, Boineau RE, Higginbotham MB, et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 1989; 64:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/20\">",
"      Reilly DF, McNeely MJ, Doerner D, et al. Self-reported exercise tolerance and the risk of serious perioperative complications. Arch Intern Med 1999; 159:2185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/21\">",
"      Wilson RJ, Davies S, Yates D, et al. Impaired functional capacity is associated with all-cause mortality after major elective intra-abdominal surgery. Br J Anaesth 2010; 105:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/22\">",
"      Yap CH, Zimmet A, Mohajeri M, Yii M. Effect of obesity on early morbidity and mortality following cardiac surgery. Heart Lung Circ 2007; 16:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/23\">",
"      Kuduvalli M, Grayson AD, Oo AY, et al. Risk of morbidity and in-hospital mortality in obese patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg 2002; 22:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/24\">",
"      Zacharias A, Schwann TA, Riordan CJ, et al. Obesity and risk of new-onset atrial fibrillation after cardiac surgery. Circulation 2005; 112:3247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/25\">",
"      Klasen J, Junger A, Hartmann B, et al. Increased body mass index and peri-operative risk in patients undergoing non-cardiac surgery. Obes Surg 2004; 14:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/26\">",
"      Mullen JT, Moorman DW, Davenport DL. The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg 2009; 250:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/27\">",
"      Dindo D, Muller MK, Weber M, Clavien PA. Obesity in general elective surgery. Lancet 2003; 361:2032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/28\">",
"      Thomas EJ, Goldman L, Mangione CM, et al. Body mass index as a correlate of postoperative complications and resource utilization. Am J Med 1997; 102:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/29\">",
"      Herrera FA, Yanagawa J, Johnson A, et al. The prevalence of obesity and postoperative complications in a Veterans Affairs Medical Center general surgery population. Am Surg 2007; 73:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/30\">",
"      Hofer RE, Kai T, Decker PA, Warner DO. Obesity as a risk factor for unanticipated admissions after ambulatory surgery. Mayo Clin Proc 2008; 83:908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/31\">",
"      Smetana GW. Preoperative pulmonary evaluation. N Engl J Med 1999; 340:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/32\">",
"      Kaw R, Pasupuleti V, Walker E, et al. Postoperative complications in patients with obstructive sleep apnea. Chest 2012; 141:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/33\">",
"      T&oslash;nnesen H, Nielsen PR, Lauritzen JB, M&oslash;ller AM. Smoking and alcohol intervention before surgery: evidence for best practice. Br J Anaesth 2009; 102:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/34\">",
"      Bradley KA, Rubinsky AD, Sun H, et al. Alcohol screening and risk of postoperative complications in male VA patients undergoing major non-cardiac surgery. J Gen Intern Med 2011; 26:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/35\">",
"      Harris AH, Reeder R, Ellerbe L, et al. Preoperative alcohol screening scores: association with complications in men undergoing total joint arthroplasty. J Bone Joint Surg Am 2011; 93:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/36\">",
"      Rubinsky AD, Sun H, Blough DK, et al. AUDIT-C alcohol screening results and postoperative inpatient health care use. J Am Coll Surg 2012; 214:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/37\">",
"      Tonnesen H, Rosenberg J, Nielsen HJ, et al. Effect of preoperative abstinence on poor postoperative outcome in alcohol misusers: randomised controlled trial. BMJ 1999; 318:1311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/38\">",
"      Jones R, Nyawo B, Jamieson S, Clark S. Current smoking predicts increased operative mortality and morbidity after cardiac surgery in the elderly. Interact Cardiovasc Thorac Surg 2011; 12:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/39\">",
"      Mills E, Eyawo O, Lockhart I, et al. Smoking cessation reduces postoperative complications: a systematic review and meta-analysis. Am J Med 2011; 124:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/40\">",
"      Myers K, Hajek P, Hinds C, McRobbie H. Stopping smoking shortly before surgery and postoperative complications: a systematic review and meta-analysis. Arch Intern Med 2011; 171:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/41\">",
"      Macpherson DS, Snow R, Lofgren RP. Preoperative screening: value of previous tests. Ann Intern Med 1990; 113:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/42\">",
"      Macpherson DS. Preoperative laboratory testing: should any tests be \"routine\" before surgery? Med Clin North Am 1993; 77:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/43\">",
"      Garc&iacute;a-Miguel FJ, Serrano-Aguilar PG, L&oacute;pez-Bastida J. Preoperative assessment. Lancet 2003; 362:1749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/44\">",
"      Committee on Standards and Practice Parameters, Apfelbaum JL, Connis RT, et al. Practice advisory for preanesthesia evaluation: an updated report by the American Society of Anesthesiologists Task Force on Preanesthesia Evaluation. Anesthesiology 2012; 116:522.",
"     </a>",
"    </li>",
"    <li>",
"     Association of Anaesthetists of Great Britain and Ireland. AAGBI safety guideline. Pre-operative assessment and patient preparation. The role of the anaesthetist. January 2010. London. file://www.aagbi.org/sites/default/files/preop2010.pdf (Accessed on June 27, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/46\">",
"      Wu WC, Schifftner TL, Henderson WG, et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007; 297:2481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/47\">",
"      Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365:2453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/48\">",
"      Bushick JB, Eisenberg JM, Kinman J, et al. Pursuit of abnormal coagulation screening tests generates modest hidden preoperative costs. J Gen Intern Med 1989; 4:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/49\">",
"      Turnbull JM, Buck C. The value of preoperative screening investigations in otherwise healthy individuals. Arch Intern Med 1987; 147:1101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/50\">",
"      Velanovich V. The value of routine preoperative laboratory testing in predicting postoperative complications: a multivariate analysis. Surgery 1991; 109:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/51\">",
"      Mathew A, Devereaux PJ, O'Hare A, et al. Chronic kidney disease and postoperative mortality: a systematic review and meta-analysis. Kidney Int 2008; 73:1069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/52\">",
"      Eagle KA, Coley CM, Newell JB, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989; 110:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/53\">",
"      Higgins TL, Estafanous FG, Loop FD, et al. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. JAMA 1992; 267:2344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/54\">",
"      Grek S, Gravenstein N, Morey TE, Rice MJ. A cost-effective screening method for preoperative hyperglycemia. Anesth Analg 2009; 109:1622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/55\">",
"      Powell-Jackson P, Greenway B, Williams R. Adverse effects of exploratory laparotomy in patients with unsuspected liver disease. Br J Surg 1982; 69:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/56\">",
"      van Veen JJ, Spahn DR, Makris M. Routine preoperative coagulation tests: an outdated practice? Br J Anaesth 2011; 106:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/57\">",
"      Suchman AL, Mushlin AI. How well does the activated partial thromboplastin time predict postoperative hemorrhage? JAMA 1986; 256:750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/58\">",
"      Si&eacute; P, Steib A. Central laboratory and point of care assessment of perioperative hemostasis. Can J Anaesth 2006; 53:S12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/59\">",
"      Seicean A, Schiltz NK, Seicean S, et al. Use and utility of preoperative hemostatic screening and patient history in adult neurosurgical patients. J Neurosurg 2012; 116:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/60\">",
"      Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 1990; 16:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/61\">",
"      Peterson P, Hayes TE, Arkin CF, et al. The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article. Arch Surg 1998; 133:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/62\">",
"      Chee YL, Crawford JC, Watson HG, Greaves M. Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology. Br J Haematol 2008; 140:496.",
"     </a>",
"    </li>",
"    <li>",
"     Danielson D, Bjork K, Card R, et al. Institute for Clinical Systems Improvement. Preoperative Evaluation. Available at: file://www.icsi.org/preoperative_evaluation/preoperative_evaluation_2328.html (Accessed on August 30, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/64\">",
"      Koulouvaris P, Sculco P, Finerty E, et al. Relationship between perioperative urinary tract infection and deep infection after joint arthroplasty. Clin Orthop Relat Res 2009; 467:1859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/65\">",
"      David TS, Vrahas MS. Perioperative lower urinary tract infections and deep sepsis in patients undergoing total joint arthroplasty. J Am Acad Orthop Surg 2000; 8:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/66\">",
"      Lawrence VA, Kroenke K. The unproven utility of preoperative urinalysis. Clinical use. Arch Intern Med 1988; 148:1370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/67\">",
"      Ollivere BJ, Ellahee N, Logan K, et al. Asymptomatic urinary tract colonisation predisposes to superficial wound infection in elective orthopaedic surgery. Int Orthop 2009; 33:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/68\">",
"      Lawrence VA, Gafni A, Gross M. The unproven utility of the preoperative urinalysis: economic evaluation. J Clin Epidemiol 1989; 42:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/69\">",
"      Lamont T, Coates T, Mathew D, et al. Checking for pregnancy before surgery: summary of a safety report from the National Patient Safety Agency. BMJ 2010; 341:c3402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/70\">",
"      Ramoska EA, Sacchetti AD, Nepp M. Reliability of patient history in determining the possibility of pregnancy. Ann Emerg Med 1989; 18:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/71\">",
"      Goldberger AL, O'Konski M. Utility of the routine electrocardiogram before surgery and on general hospital admission. Critical review and new guidelines. Ann Intern Med 1986; 105:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/72\">",
"      Liu LL, Dzankic S, Leung JM. Preoperative electrocardiogram abnormalities do not predict postoperative cardiac complications in geriatric surgical patients. J Am Geriatr Soc 2002; 50:1186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/73\">",
"      Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery, European Society of Cardiology (ESC), Poldermans D, et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 2009; 30:2769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/74\">",
"      Poirier P, Alpert MA, Fleisher LA, et al. Cardiovascular evaluation and management of severely obese patients undergoing surgery: a science advisory from the American Heart Association. Circulation 2009; 120:86.",
"     </a>",
"    </li>",
"    <li>",
"     The Swedish Council on Technology Assessment in Health Care (SBU). Preoperative routines. Stockholm: SBU, 1989.",
"    </li>",
"    <li>",
"     Agence Nationale pour le Development de l'Evaluation Medicale (ANDEM). Indication of Preoperative Tests. Paris: ANDEM, 1992.",
"    </li>",
"    <li>",
"     Guidelines and Protocols Advisory Committee (GPAC), Medical Services Commission, and British Columbia Medical Association. Guideline for Routine Pre-Operative Testing. Victoria BC: Ministry of Health, 2000.",
"    </li>",
"    <li>",
"     National Institute for Clinical Excellence (2003) Guidance on the use of preoperative tests for elective surgery. NICE Clinical Guideline No 3. London: National Institute for Clinical Excellence, 2003.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/79\">",
"      Archer C, Levy AR, McGregor M. Value of routine preoperative chest x-rays: a meta-analysis. Can J Anaesth 1993; 40:1022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/80\">",
"      Rucker L, Frye EB, Staten MA. Usefulness of screening chest roentgenograms in preoperative patients. JAMA 1983; 250:3209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/4/10314/abstract/81\">",
"      Lawrence VA, Dhanda R, Hilsenbeck SG, Page CP. Risk of pulmonary complications after elective abdominal surgery. Chest 1996; 110:744.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4816 Version 21.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-14.112.150.18-37D25D05A2-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_4_10314=[""].join("\n");
var outline_f10_4_10314=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      RATIONALE FOR SELECTIVE TESTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Predictive value",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Screening questionnaire",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Exercise capacity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Medication use",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Obesity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6631824\">",
"      Obstructive sleep apnea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7355406\">",
"      Alcohol misuse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33505198\">",
"      Smoking",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6635260\">",
"      Personal or family history of anesthetic complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      LABORATORY EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Timing of laboratory testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Laboratory studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Complete blood count",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Renal function",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Electrolytes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Blood glucose",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Liver function tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Tests of hemostasis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Urinalysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2750321\">",
"      - Pregnancy testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      ELECTROCARDIOGRAM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      CHEST RADIOGRAPH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      PULMONARY FUNCTION TESTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/4816\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/4816|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/52/3915\" title=\"table 1\">",
"      Probability abnormal test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/53/859\" title=\"table 2\">",
"      Predictive value positive tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?27/45/28380\" title=\"table 3\">",
"      Likelihood ratios preop tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/36/38475\" title=\"table 4\">",
"      Preop evaluation questions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/33/8733\" title=\"table 5\">",
"      American Society of Anesthesiologists physical status scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/42/13996\" title=\"table 6\">",
"      AUDIT-C",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/6/19564\" title=\"table 7\">",
"      ACC AHA preoperative ECG",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44808?source=related_link\">",
"      Clinical manifestations and diagnosis of early pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=related_link\">",
"      Estimation of cardiac risk prior to noncardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/8/1162?source=related_link\">",
"      Evaluation of preoperative pulmonary risk",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32984?source=related_link\">",
"      Malignant hyperthermia: Clinical diagnosis and management of acute crisis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/3/23609?source=related_link\">",
"      Overview of smoking cessation management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/48/41735?source=related_link\">",
"      Overview of the principles of medical consultation and perioperative medicine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?29/52/30530?source=related_link\">",
"      Patient information: Questions to ask if you are having a procedure or surgery (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/45/40666?source=related_link\">",
"      Perioperative medication management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/43/32439?source=related_link\">",
"      Preoperative assessment of hemostasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/52/41802?source=related_link\">",
"      Prevention of venous thromboembolic disease in surgical patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12904?source=related_link\">",
"      Smoking cessation counseling strategies in primary care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35288?source=related_link\">",
"      Surgical risk and the preoperative evaluation and management of adults with obstructive sleep apnea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/3/36921?source=related_link\">",
"      Susceptibility to malignant hyperthermia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_4_10315="Dialysate components in HD";
var content_f10_4_10315=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F70013&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F70013&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Concentrations of dialysate components used in hemodialysis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Sodium (meq/L)",
"       </td>",
"       <td>",
"        135 to 155",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Potassium (meq/L)",
"       </td>",
"       <td>",
"        0 to 4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Calcium (mmol/L)",
"       </td>",
"       <td>",
"        1.25 to 1.75 (2.5 to 3.5 meq/L)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Magnesium (mmol/L)",
"       </td>",
"       <td>",
"        0 to 0.75 (0 to 1.5 meq/L)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chloride (meq/L)",
"       </td>",
"       <td>",
"        87 to 120",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bicarbonate (meq/L)",
"       </td>",
"       <td>",
"        25 to 40",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Glucose (g/dL)",
"       </td>",
"       <td>",
"        0 to 0.20",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Van Stone, JC. Hemodialysis: Hemodialysis apparatus. In: Handbook of Dialysis Daugirdas, JT, Ing, TS (Eds), Little, Brown, Boston, 1994. p. 53.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_4_10315=[""].join("\n");
var outline_f10_4_10315=null;
var title_f10_4_10316="Criteria for acute kidney injury";
var content_f10_4_10316=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F83168&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F83168&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Criteria for acute kidney injury",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Serum creatinine criteria",
"       </td>",
"       <td class=\"subtitle1\">",
"        Urine output criteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        RIFLE",
"       </td>",
"       <td>",
"        Definition",
"       </td>",
"       <td>",
"        Increase in SCr by &ge;1.5 times baseline within seven days",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Staging",
"       </td>",
"       <td>",
"        R (Risk): Increase in SCr by 1.5 - &lt;2.0 times baseline",
"       </td>",
"       <td>",
"        UO &lt;0.5 mL/kg/h x 6 hr",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        I (Injury): Increase in SCr by 2.0 - &lt;3.0 times baseline",
"       </td>",
"       <td>",
"        UO &lt;0.5 mL/kg/h x 12 hr",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        F (Failure): Increase in SCr by &ge;3.0 times baseline",
"       </td>",
"       <td>",
"        UO &lt;0.3 mL/kg/h x 24 hr or anuria x 12 hrs",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        AKIN",
"       </td>",
"       <td>",
"        Definition",
"       </td>",
"       <td>",
"        Increase in SCr by 0.3 mg/dL or &ge;1.5 times baseline within 48 hours",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Staging",
"       </td>",
"       <td>",
"        1: Increase in SCr by &ge;0.3 mg/dL or &ge;1.5 - &lt;2.0 times baseline",
"       </td>",
"       <td>",
"        Less than 0.5 mL/kg per hour for more than 6 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2: Increase in SCr by &ge;2.0 - &lt;3.0 times baseline",
"       </td>",
"       <td>",
"        Less than 0.5 mL/kg per hour for more than 12 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3: Increase in SCr by &ge;3.0 times baseline",
"       </td>",
"       <td>",
"        Less than 0.3 mL/kg per hour for 24 hours or anuria for 12 hours",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:B204. Copyright &copy; 2004 BioMed Central Ltd.",
"      </li>",
"      <li>",
"       Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31. Copyright &copy; 2007 BioMed Central Ltd.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_4_10316=[""].join("\n");
var outline_f10_4_10316=null;
var title_f10_4_10317="Evaluation metabolic myopathy";
var content_f10_4_10317=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F56365&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F56365&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Evaluation of the patient with suspected metabolic myopathy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        General investigations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Blood",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Creatinine kinase blood level (at rest, during episodes)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lactate, pyruvate, LDH, LFTs, uric acid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        CBC, electrolytes, glucose",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lactate, pyruvate, and lactate/pyruvate ratio",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        ALT, AST, LDH",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Carnitine - free, total, and free/total ratio",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ketones",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Myoglobin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ca, K, PO4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Urine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Myoglobin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ketones",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Specific investigations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Cardiac evaluation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Electrocardiogram",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Echocardiogram",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Lipid metabolism defects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Plasma carnitine - free, total, free/total ratio",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Serum acylcarnitines, free fatty acids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Serum glucose, ammonia, ketones",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Serum free fatty acid/ketone ratio",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Urine dicarboxylic acids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Urine acylglycines and organic acids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Skin fibroblast culture for enzyme assay",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Electromyogram and nerve conduction studies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Biochemical and/or molecular studies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Glycolytic/glycogenolytic defects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        CBC, reticulocyte count, bilirubin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Electromyogram and nerve conduction studies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Muscle and skin biopsies for histology and enzyme assays",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Biochemical and/or molecular studies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Mitochondrial defects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Other system evaluation (eg, endocrine, cardiac)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Serum lactate, pyruvate, lactate/pyruvate ratio",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        CSF lactate, pyruvate, and lactate/pyruvate ratio",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Urine organic acids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        MRI spectroscopy of muscle and brain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Electromyogram and nerve conduction studies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Muscle and skin biopsies for histology and enzyme assays",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Biochemical and/or molecular",
"studies",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ALT: serum alanine aminotransferase; AST: serum aspartate aminotransferase; CBC: complete blood count; CSF: cerebrospinal fluid; LDH: lactate dehydrogenase; LFT: liver function tests; MRI: magnetic resonance imaging.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_4_10317=[""].join("\n");
var outline_f10_4_10317=null;
var title_f10_4_10318="Contents: Spinal disease and back pain";
var content_f10_4_10318=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?0/63/1022\">",
"       Neurology",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Spinal disease and back pain",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Spinal disease and back pain",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Ankylosing spondylitis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/23/35194\">",
"           Assessment and treatment of ankylosing spondylitis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/9/151\">",
"           Clinical manifestations of ankylosing spondylitis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/51/12090\">",
"           Pathogenesis of spondyloarthritis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Low back pain",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/10/18601\">",
"           Approach to the diagnosis and evaluation of low back pain in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/7/14458\">",
"           Clinical manifestations and treatment of osteoporotic thoracolumbar vertebral compression fractures",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/21/12633\">",
"           Diagnostic testing for low back pain",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/43/6841\">",
"           Exercise-based therapy for low back pain",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/28/1480\">",
"           Lumbar spinal stenosis: Pathophysiology, clinical features, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/15/22776\">",
"           Lumbar spinal stenosis: Treatment and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/34/42535\">",
"           Occupational low back pain: Evaluation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/47/14072\">",
"           Occupational low back pain: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/16/41222\">",
"           Spinal manipulation in the treatment of musculoskeletal pain",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/52/39753\">",
"           Subacute and chronic low back pain: Nonsurgical interventional treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/24/19850\">",
"           Subacute and chronic low back pain: Pharmacologic and noninterventional treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/5/34905\">",
"           Subacute and chronic low back pain: Surgical treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/21/13658\">",
"           Treatment of acute low back pain",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neck pain",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/18/27944\">",
"           Cervical spondylotic myelopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/19/36152\">",
"           Clinical features and diagnosis of cervical radiculopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/24/1418\">",
"           Evaluation of the patient with neck pain and cervical spine disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/47/17144\">",
"           Treatment of cervical radiculopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/36/23113\">",
"           Treatment of neck pain",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/6/35940\">",
"           Coccydynia (coccygodynia)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/16/41222\">",
"           Spinal manipulation in the treatment of musculoskeletal pain",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-FB7F6DD619-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f10_4_10318=[""].join("\n");
var outline_f10_4_10318=null;
var title_f10_4_10319="Antibodies to GBS conjugates";
var content_f10_4_10319=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F79484&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F79484&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Immunogenicity of candidate conjugate vaccines against Group B streptococcus in healthy women of childbearing age",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 440px; height: 553px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CPS: Capsular polysaccharide; TT: Tetanus toxoid.",
"    <br>",
"     <br>",
"      Type Ia-TT and Ib-TT conjugate vaccines were well tolerated by healthy, childbearing-age women, and the serotype-specific IgG response was significantly greater in recipients of the conjugate compared&nbsp;with the uncoupled CPS vaccine. Subjects were randomized to receive (panel A) Ia-TT vaccine (red line, n = 30), uncoupled Ia CPS (blue line, n = 30), or saline placebo (green line, n = 15); or (panel B) Ib-TT vaccine (red line, n = 30), uncoupled Ib CPS (blue line, n = 15), or saline placebo (green line, n = 10).",
"      <br>",
"       <div class=\"footnotes\">",
"       </div>",
"       <div class=\"reference\">",
"        Data from Baker CJ, Paoletti LC, Wessels MR, et al. J Infect Dis 1999; 179:142.",
"       </div>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_4_10319=[""].join("\n");
var outline_f10_4_10319=null;
